Cover Page
Cover Page - shares | 3 Months Ended | |
Oct. 28, 2023 | Nov. 16, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Oct. 28, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-39940 | |
Entity Registrant Name | CISCO SYSTEMS, INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 77-0059951 | |
Entity Address, Address Line One | 170 West Tasman Drive | |
Entity Address, City or Town | San Jose | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 95134 | |
City Area Code | 408 | |
Local Phone Number | 526-4000 | |
Title of 12(b) Security | Common Stock, par value $0.001 per share | |
Trading Symbol | CSCO | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding (in shares) | 4,063,475,676 | |
Amendment Flag | false | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2024 | |
Entity Central Index Key | 0000858877 | |
Current Fiscal Year End Date | --07-27 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 9,602 | $ 10,123 |
Investments | 13,921 | 16,023 |
Accounts receivable, net of allowance of $82 at October 28, 2023 and $85 at July 29, 2023 | 4,833 | 5,854 |
Inventories | 3,342 | 3,644 |
Financing receivables, net | 3,414 | 3,352 |
Other current assets | 4,547 | 4,352 |
Total current assets | 39,659 | 43,348 |
Property and equipment, net | 2,004 | 2,085 |
Financing receivables, net | 3,324 | 3,483 |
Goodwill | 38,900 | 38,535 |
Purchased intangible assets, net | 1,914 | 1,818 |
Deferred tax assets | 7,102 | 6,576 |
Other assets | 5,879 | 6,007 |
TOTAL ASSETS | 98,782 | 101,852 |
Current liabilities: | ||
Short-term debt | 990 | 1,733 |
Accounts payable | 2,084 | 2,313 |
Income taxes payable | 2,380 | 4,235 |
Accrued compensation | 3,039 | 3,984 |
Deferred revenue | 13,812 | 13,908 |
Other current liabilities | 4,730 | 5,136 |
Total current liabilities | 27,035 | 31,309 |
Long-term debt | 6,660 | 6,658 |
Income taxes payable | 5,790 | 5,756 |
Deferred revenue | 11,847 | 11,642 |
Other long-term liabilities | 2,240 | 2,134 |
Total liabilities | 53,572 | 57,499 |
Commitments and contingencies (Note 14) | ||
Cisco stockholders’ equity: | ||
Preferred stock, $0.001 par value: 5 shares authorized; none issued and outstanding | 0 | 0 |
Common stock and additional paid-in capital, $0.001 par value: 20,000 shares authorized; 4,049 and 4,066 shares issued and outstanding at October 28, 2023 and July 29, 2023, respectively | 44,546 | 44,289 |
Retained earnings | 2,689 | 1,639 |
Accumulated other comprehensive loss | (2,025) | (1,575) |
Total equity | 45,210 | 44,353 |
TOTAL LIABILITIES AND EQUITY | $ 98,782 | $ 101,852 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance | $ 82 | $ 85 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 20,000,000,000 | 20,000,000,000 |
Common stock, shares issued (in shares) | 4,049,000,000 | 4,066,000,000 |
Common stock, shares outstanding (in shares) | 4,049,000,000 | 4,066,000,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
REVENUE: | ||
Total revenue | $ 14,668 | $ 13,632 |
COST OF SALES: | ||
Total cost of sales | 5,111 | 5,286 |
GROSS MARGIN | 9,557 | 8,346 |
OPERATING EXPENSES: | ||
Research and development | 1,913 | 1,781 |
Sales and marketing | 2,506 | 2,391 |
General and administrative | 672 | 565 |
Amortization of purchased intangible assets | 67 | 71 |
Restructuring and other charges | 123 | (2) |
Total operating expenses | 5,281 | 4,806 |
OPERATING INCOME | 4,276 | 3,540 |
Interest income | 360 | 169 |
Interest expense | (111) | (100) |
Other income (loss), net | (83) | (134) |
Interest and other income (loss), net | 166 | (65) |
INCOME BEFORE PROVISION FOR INCOME TAXES | 4,442 | 3,475 |
Provision for income taxes | 804 | 805 |
NET INCOME | $ 3,638 | $ 2,670 |
Net income per share: | ||
Basic (in dollars per share) | $ 0.90 | $ 0.65 |
Diluted (in dollars per share) | $ 0.89 | $ 0.65 |
Shares used in per-share calculation: | ||
Basic (in shares) | 4,057 | 4,108 |
Diluted (in shares) | 4,087 | 4,116 |
Product | ||
REVENUE: | ||
Total revenue | $ 11,139 | $ 10,245 |
COST OF SALES: | ||
Total cost of sales | 3,957 | 4,179 |
Service | ||
REVENUE: | ||
Total revenue | 3,529 | 3,387 |
COST OF SALES: | ||
Total cost of sales | $ 1,154 | $ 1,107 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 3,638 | $ 2,670 |
Available-for-sale investments: | ||
Change in net unrealized gains and losses, net of tax benefit (expense) of $40 and $78 for the first quarter of fiscal 2024 and 2023, respectively | (130) | (251) |
Net (gains) losses reclassified into earnings, net of tax (benefit) expense of $(4) and $(1) for the first quarter of fiscal 2024 and 2023, respectively | 16 | 5 |
Total- Available-for-sale investments | (114) | (246) |
Cash flow hedging instruments: | ||
Change in unrealized gains and losses, net of tax benefit (expense) of $(9) and $(8) for the first quarter of fiscal 2024 and 2023, respectively | 29 | 24 |
Net (gains) losses reclassified into earnings, net of tax (benefit) expense of $3 and $5 for the first quarter of fiscal 2024 and 2023, respectively | (9) | (14) |
Total- Cash flow hedging instruments | 20 | 10 |
Net change in cumulative translation adjustment and actuarial gains and losses net of tax benefit (expense) of $1 and $22 for the first quarter of fiscal 2024 and 2023, respectively | (356) | (260) |
Other comprehensive income (loss) | (450) | (496) |
Comprehensive income | $ 3,188 | $ 2,174 |
Consolidated Statements of Co_2
Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Change in net unrealized gains and losses, tax benefit (expense), available-for-sale investments | $ 40 | $ 78 |
Net (gains) losses reclassified into earnings, tax (benefit) expense, available-for-sale investments | (4) | (1) |
Change in unrealized gains and losses, tax benefit (expense), cash flow hedging instruments | (9) | (8) |
Net (gains) losses reclassified into earnings, tax (benefit) expense, cash flow hedging instruments | 3 | 5 |
Net change in cumulative translation adjustment and actuarial gains and losses, net of tax benefit (expense) | $ 1 | $ 22 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Cash flows from operating activities: | ||
Net income | $ 3,638 | $ 2,670 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation, amortization, and other | 401 | 415 |
Share-based compensation expense | 661 | 496 |
Provision (benefit) for receivables | 4 | 7 |
Deferred income taxes | (513) | (366) |
(Gains) losses on divestitures, investments and other, net | 89 | 131 |
Change in operating assets and liabilities, net of effects of acquisitions and divestitures: | ||
Accounts receivable | 979 | 1,119 |
Inventories | 307 | (108) |
Financing receivables | 25 | 556 |
Other assets | (290) | (316) |
Accounts payable | (235) | 42 |
Income taxes, net | (1,773) | 20 |
Accrued compensation | (908) | (384) |
Deferred revenue | 259 | (78) |
Other liabilities | (273) | (242) |
Net cash provided by operating activities | 2,371 | 3,962 |
Cash flows from investing activities: | ||
Purchases of investments | (1,850) | (1,943) |
Proceeds from sales of investments | 1,280 | 407 |
Proceeds from maturities of investments | 2,497 | 971 |
Acquisitions, net of cash and cash equivalents acquired and divestitures | (876) | 0 |
Purchases of investments in privately held companies | (13) | (48) |
Return of investments in privately held companies | 47 | 10 |
Acquisition of property and equipment | (134) | (176) |
Other | 1 | (20) |
Net cash provided by (used in) investing activities | 952 | (799) |
Cash flows from financing activities: | ||
Repurchases of common stock—repurchase program | (1,300) | (556) |
Shares repurchased for tax withholdings on vesting of restricted stock units | (153) | (108) |
Short-term borrowings, original maturities of 90 days or less, net | 0 | (602) |
Repayments of debt | (750) | 0 |
Dividends paid | (1,580) | (1,560) |
Other | (17) | (29) |
Net cash used in financing activities | (3,800) | (2,855) |
Effect of foreign currency exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents | (45) | (95) |
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | (522) | 213 |
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period | 11,627 | 8,579 |
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period | 11,105 | 8,792 |
Supplemental cash flow information: | ||
Cash paid for interest | 128 | 114 |
Cash paid for income taxes, net | $ 3,090 | $ 1,150 |
Consolidated Statements of Equi
Consolidated Statements of Equity - USD ($) shares in Millions, $ in Millions | Total | Shares of Common Stock | Common Stock and Additional Paid-In Capital | Retained Earnings (Accumulated Deficit) | Accumulated Other Comprehensive Loss |
Beginning balance (in shares) at Jul. 30, 2022 | 4,110 | ||||
Beginning balance at Jul. 30, 2022 | $ 39,773 | $ 42,714 | $ (1,319) | $ (1,622) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net income | 2,670 | 2,670 | |||
Other comprehensive loss | (496) | (496) | |||
Issuance of common stock (in shares) | 7 | ||||
Issuance of common stock | $ 0 | 0 | |||
Repurchase of common stock (in shares) | (12) | (12) | |||
Repurchase of common stock | $ (502) | (118) | (384) | ||
Shares repurchased for tax withholdings on vesting of restricted stock units and other (in shares) | (2) | ||||
Shares repurchased for tax withholdings on vesting of restricted stock units and other | (108) | (108) | |||
Cash dividends declared | (1,560) | (1,560) | |||
Share-based compensation | 496 | 496 | |||
Other | (1) | 0 | (1) | ||
Ending balance (in shares) at Oct. 29, 2022 | 4,103 | ||||
Ending balance at Oct. 29, 2022 | 40,272 | 42,984 | (594) | (2,118) | |
Beginning balance (in shares) at Jul. 29, 2023 | 4,066 | ||||
Beginning balance at Jul. 29, 2023 | 44,353 | 44,289 | 1,639 | (1,575) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Net income | 3,638 | 3,638 | |||
Other comprehensive loss | (450) | (450) | |||
Issuance of common stock (in shares) | 9 | ||||
Issuance of common stock | $ 0 | 0 | |||
Repurchase of common stock (in shares) | (23) | (23) | |||
Repurchase of common stock | $ (1,252) | (249) | (1,003) | ||
Shares repurchased for tax withholdings on vesting of restricted stock units and other (in shares) | (3) | ||||
Shares repurchased for tax withholdings on vesting of restricted stock units and other | (156) | (156) | |||
Cash dividends declared | (1,580) | (1,580) | |||
Share-based compensation | 661 | 661 | |||
Other | (4) | 1 | (5) | ||
Ending balance (in shares) at Oct. 28, 2023 | 4,049 | ||||
Ending balance at Oct. 28, 2023 | $ 45,210 | $ 44,546 | $ 2,689 | $ (2,025) |
Consolidated Statements of Eq_2
Consolidated Statements of Equity (Parenthetical) - $ / shares | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Statement of Stockholders' Equity [Abstract] | ||
Cash dividends declared (in dollars per share) | $ 0.39 | $ 0.38 |
Organization and Basis of Prese
Organization and Basis of Presentation | 3 Months Ended |
Oct. 28, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Basis of Presentation | Organization and Basis of Presentation The fiscal year for Cisco Systems, Inc. (the “Company,” “Cisco,” “we,” “us,” or “our”) is the 52 or 53 weeks ending on the last Saturday in July. Fiscal 2024 and fiscal 2023 are each 52-week fiscal years. The Consolidated Financial Statements include our accounts and those of our subsidiaries. All intercompany accounts and transactions have been eliminated. We conduct business globally and are primarily managed on a geographic basis in the following three geographic segments: the Americas; Europe, Middle East, and Africa (EMEA); and Asia Pacific, Japan, and China (APJC). We have prepared the accompanying financial data as of October 28, 2023 and for the first quarter of fiscal 2024 and 2023, without audit, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (GAAP) have been condensed or omitted pursuant to such rules and regulations. The July 29, 2023 Consolidated Balance Sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented not misleading. These Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended July 29, 2023. In the opinion of management, all normal recurring adjustments necessary to state fairly the consolidated balance sheet as of October 28, 2023, the results of operations, the statements of comprehensive income, the statements of cash flows and the statements of equity for the first quarter of fiscal 2024 and 2023, as applicable, have been made. The results of operations for the first quarter of fiscal 2024 are not necessarily indicative of the operating results for the full fiscal year or any future periods. Our consolidated financial statements include our accounts and investments consolidated under the voting interest model. The noncontrolling interests attributed to these investments are not presented as a separate component in the equity section of the Consolidated Balance Sheets as these amounts are not material for any of the fiscal periods presented. The share of earnings attributable to the noncontrolling interests are not presented separately in the Consolidated Statements of Operations as these amounts are not material for any of the fiscal periods presented. Certain reclassifications have been made to the amounts in prior periods in order to conform to the current period’s presentation. We have evaluated subsequent events through the date that the financial statements were issued. |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 3 Months Ended |
Oct. 28, 2023 | |
Accounting Policies [Abstract] | |
Recent Accounting Pronouncements | Recent Accounting PronouncementsThere have been no recent accounting pronouncements issued that we believe will have a material impact on our Consolidated Financial Statements. |
Revenue
Revenue | 3 Months Ended |
Oct. 28, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue We enter into contracts with customers that can include various combinations of products and services which are generally distinct and accounted for as separate performance obligations. As a result, our contracts may contain multiple performance obligations. We determine whether arrangements are distinct based on whether the customer can benefit from the product or service on its own or together with other resources that are readily available and whether our commitment to transfer the product or service to the customer is separately identifiable from other obligations in the contract. We classify our hardware, perpetual software licenses, and software-as-a-service (SaaS) as distinct performance obligations. Term software licenses represent multiple obligations, which include software licenses and software maintenance. In transactions where we deliver hardware or software, we are typically the principal and we record revenue and costs of goods sold on a gross basis. We refer to our term software licenses, security software licenses, SaaS, and associated service arrangements as subscription offers. We recognize revenue upon transfer of control of promised goods or services in a contract with a customer in an amount that reflects the consideration we expect to receive in exchange for those products or services. Transfer of control occurs once the customer has the contractual right to use the product, generally upon shipment, electronic delivery (or when the software is available for download by the customer), or once title and risk of loss has transferred to the customer. Transfer of control can also occur over time for software maintenance and services as the customer receives the benefit over the contract term. Our hardware and perpetual software licenses are distinct performance obligations where revenue is recognized upfront upon transfer of control. Term software licenses include multiple performance obligations where the term licenses are recognized upfront upon transfer of control, with the associated software maintenance revenue recognized ratably over the contract term as services and software updates are provided. SaaS arrangements do not include the right for the customer to take possession of the software during the term, and therefore have one distinct performance obligation which is satisfied over time with revenue recognized ratably over the contract term as the customer consumes the services. On our product sales, we record consideration from shipping and handling on a gross basis within net product sales. We record our revenue net of any associated sales taxes. An allowance for future sales returns is established based on historical trends in product return rates. The allowance for future sales returns as of October 28, 2023 and July 29, 2023 was $37 million and $39 million, respectively, and was recorded as a reduction of our accounts receivable and revenue. Significant Judgments Revenue is allocated among these performance obligations in a manner that reflects the consideration that we expect to be entitled to for the promised goods or services based on standalone selling prices (SSP). SSP is estimated for each distinct performance obligation and judgment may be required in their determination. The best evidence of SSP is the observable price of a product or service when we sell the goods separately in similar circumstances and to similar customers. In instances where SSP is not directly observable, we determine SSP using information that may include market conditions and other observable inputs. We assess relevant contractual terms in our customer contracts to determine the transaction price. We apply judgment in identifying contractual terms and determining the transaction price as we may be required to estimate variable consideration when determining the amount of revenue to recognize. Variable consideration includes potential contractual penalties and various rebate, cooperative marketing and other incentive programs that we offer to our distributors, channel partners and customers. When determining the amount of revenue to recognize, we estimate the expected usage of these programs, applying the expected value or most likely estimate and update the estimate at each reporting period as actual utilization becomes available. We also consider the customers’ right of return in determining the transaction price, where applicable. We assess certain software licenses, such as for security software, that contain critical updates or upgrades which customers can download throughout the contract term. Without these updates or upgrades, the functionality of the software would diminish over a relatively short time period. These updates or upgrades provide the customer the full functionality of the purchased security software licenses and are required to maintain the security license’s utility as the risks and threats in the environment are rapidly changing. In these circumstances, the revenue from these software arrangements is recognized as a single performance obligation satisfied over the contract term. (a) Disaggregation of Revenue We disaggregate our revenue into groups of similar products and services that depict the nature, amount, and timing of revenue and cash flows for our various offerings. The sales cycle, contractual obligations, customer requirements, and go-to-market strategies differ for each of our product categories, resulting in different economic risk profiles for each category. Effective in the first quarter of fiscal 2024, we began reporting our product and service revenue in the following categories: Networking, Security, Collaboration, Observability, and Services and conformed our product revenue for prior periods to the current period presentation. The following table presents this disaggregation of revenue (in millions): Three Months Ended October 28, October 29, Product revenue: Networking $ 8,822 $ 8,031 Security 1,010 971 Collaboration 1,117 1,086 Observability 190 157 Total Product 11,139 10,245 Services 3,529 3,387 Total $ 14,668 $ 13,632 Amounts may not sum due to rounding. Networking consists of our core networking technologies of switching, routing, wireless, 5G, silicon, optics solutions and compute products. These technologies consist of both hardware and software offerings, including software licenses and SaaS. Our hardware and perpetual software in this category are distinct performance obligations where revenue is recognized upfront upon transfer of control. Term software licenses are multiple performance obligations where the term license is recognized upfront upon transfer of control with the associated software maintenance revenue recognized ratably over the contract term. SaaS arrangements in this category have one distinct performance obligation which is satisfied over time with revenue recognized ratably over the contract term. Security consists of our Cloud and Application Security, Industrial Security, Network Security, and User and Device Security offerings. These products consist of both hardware and software offerings, including software licenses and SaaS. Updates and upgrades for the term software licenses are critical for our software to perform its intended commercial purpose because of the continuous need for our software to secure our customers’ network environments against frequent threats. Therefore, security software licenses are generally represented by a single distinct performance obligation with revenue recognized ratably over the contract term. Our hardware and perpetual software in this category are distinct performance obligations where revenue is recognized upfront upon transfer of control. SaaS arrangements in this category have one distinct performance obligation which is satisfied over time with revenue recognized ratably over the contract term. Collaboration consists of our Meetings, Collaboration Devices, Calling, Contact Center and Communication Platform as a Service (CPaaS) offerings. These products consist primarily of software offerings, including software licenses and SaaS, as well as hardware. Our perpetual software and hardware in this category are distinct performance obligations where revenue is recognized upfront upon transfer of control. Term software licenses are multiple performance obligations where the term license is recognized upfront upon transfer of control with the associated software maintenance revenue recognized ratably over the contract term. SaaS arrangements in this category have one distinct performance obligation which is satisfied over time with revenue recognized ratably over the contract term. Observability consists of our full stack observability offerings. These products consist primarily of software offerings, including software licenses and SaaS. Our perpetual software in this category are distinct performance obligations where revenue is recognized upfront upon transfer of control. Term software licenses are multiple performance obligations where the term license is recognized upfront upon transfer of control with the associated software maintenance revenue recognized ratably over the contract term. SaaS arrangements in this category have one distinct performance obligation which is satisfied over time with revenue recognized ratably over the contract term. In addition to our product offerings, we provide a broad range of service and support options for our customers, including technical support services and advanced services. Technical support services represent the majority of these offerings which are distinct performance obligations that are satisfied over time with revenue recognized ratably over the contract term. Advanced services are distinct performance obligations that are satisfied over time with revenue recognized as services are delivered. The sales arrangements as discussed above are typically made pursuant to customer purchase orders based on master purchase or partner agreements. Cash is received based on our standard payment terms which is typically 30 days. We provide financing arrangements to customers for all of our hardware, software and service offerings. Refer to Note 9 for additional information. For these arrangements, cash is typically received over time. (b) Contract Balances Accounts Receivable Accounts receivable, net was $4.8 billion as of October 28, 2023 compared to $5.9 billion as of July 29, 2023, as reported on the Consolidated Balance Sheets. The allowances for credit loss for our accounts receivable are summarized as follows (in millions): Three Months Ended October 28, 2023 October 29, 2022 Allowance for credit loss at beginning of period $ 85 $ 83 Provisions (benefits) 2 11 Recoveries (write-offs), net (5) (6) Allowance for credit loss at end of period $ 82 $ 88 Contract Assets and Liabilities Gross contract assets by our internal risk ratings are summarized as follows (in millions): October 28, July 29, 1 to 4 $ 650 $ 672 5 to 6 1,015 954 7 and Higher 68 60 Total $ 1,733 $ 1,686 Contract assets consist of unbilled receivables and are recorded when revenue is recognized in advance of scheduled billings to our customers. These amounts are primarily related to software and service arrangements where transfer of control has occurred but we have not yet invoiced. As of October 28, 2023 and July 29, 2023, our contract assets for these unbilled receivables, net of allowances, were $1.7 billion and $1.6 billion, respectively, and were included in other current assets and other assets. Contract liabilities consist of deferred revenue. Deferred revenue was $25.7 billion as of October 28, 2023 compared to $25.6 billion as of July 29, 2023. We recognized approximately $4.7 billion of revenue during the first quarter of fiscal 2024 that was included in the deferred revenue balance at July 29, 2023. (c) Capitalized Contract Acquisition Costs |
Acquisitions and Divestitures
Acquisitions and Divestitures | 3 Months Ended |
Oct. 28, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Acquisitions and Divestitures | Acquisitions and Divestitures A summary of the allocation of the total purchase consideration of our completed acquisitions during the first quarter of fiscal 2024 is presented as follows (in millions): Purchase Consideration Net Tangible Assets Acquired (Liabilities Assumed) Purchased Intangible Assets Goodwill Total acquisitions $ 896 $ (73) $ 354 $ 615 The total purchase consideration related to our acquisitions completed during the first quarter of fiscal 2024 consisted primarily of cash consideration. The total cash and cash equivalents acquired from these acquisitions was approximately $16 million. Total transaction costs related to acquisition and divestiture activities were $31 million and $2 million for the first quarter of fiscal 2024 and 2023, respectively. These transaction costs were expensed as incurred in general and administrative expenses (“G&A”) in the Consolidated Statements of Operations. The purchase price allocation for acquisitions completed during recent periods is preliminary and subject to revision as additional information about fair value of assets and liabilities becomes available. Additional information that existed as of the acquisition date but at that time was unknown to us may become known during the remainder of the measurement period, a period not to exceed 12 months from the acquisition date. The goodwill generated from acquisitions completed during the first quarter of fiscal 2024 is primarily related to expected synergies. The goodwill is generally not deductible for income tax purposes. The Consolidated Financial Statements include the operating results of each acquisition from the date of acquisition. Pro forma results of operations and the revenue and net income subsequent to the acquisition date for the acquisitions completed during the first quarter of fiscal 2024 have not been presented because the effects of the acquisitions were not material to our financial results. Intent to Acquire Splunk On September 21, 2023, we announced our intent to acquire Splunk Inc. (“Splunk”), a public cybersecurity and observability company. Under the terms of the agreement, we have agreed to pay $157 per share in cash, representing approximately $28 billion in equity value. The acquisition is expected to close by the end of the third quarter of calendar year 2024, subject to regulatory approval and other customary closing conditions, including approval by Splunk shareholders. We anticipate this transaction will be financed with a combination of cash and debt. |
Goodwill and Purchased Intangib
Goodwill and Purchased Intangible Assets | 3 Months Ended |
Oct. 28, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Purchased Intangible Assets | Goodwill and Purchased Intangible Assets (a) Goodwill The following table presents the goodwill allocated to our reportable segments as of October 28, 2023 and during the first quarter of fiscal 2024 (in millions): Balance at July 29, 2023 Acquisitions Foreign Currency Translation and Other Balance at October 28, 2023 Americas $ 24,035 $ 381 $ (156) $ 24,260 EMEA 9,118 126 (59) 9,185 APJC 5,382 108 (35) 5,455 Total $ 38,535 $ 615 $ (250) $ 38,900 (b) Purchased Intangible Assets The following table presents details of our intangible assets acquired through acquisitions completed during the first quarter of fiscal 2024 (in millions, except years): FINITE LIVES INDEFINITE LIVES TOTAL TECHNOLOGY CUSTOMER OTHER IPR&D Weighted- Amount Weighted- Amount Weighted- Amount Amount Amount Total acquisitions 4.8 $ 280 4.8 $ 58 1.0 $ 2 $ 14 $ 354 The following tables present details of our purchased intangible assets (in millions): October 28, 2023 Gross Accumulated Amortization Net Purchased intangible assets with finite lives: Technology $ 3,051 $ (1,654) $ 1,397 Customer relationships 1,186 (870) 316 Other 42 (25) 17 Total purchased intangible assets with finite lives 4,279 (2,549) 1,730 In-process research and development, with indefinite lives 184 — 184 Total $ 4,463 $ (2,549) $ 1,914 July 29, 2023 Gross Accumulated Amortization Net Purchased intangible assets with finite lives: Technology $ 2,998 $ (1,691) $ 1,307 Customer relationships 1,228 (905) 323 Other 40 (22) 18 Total purchased intangible assets with finite lives 4,266 (2,618) 1,648 In-process research and development, with indefinite lives 170 — 170 Total $ 4,436 $ (2,618) $ 1,818 Purchased intangible assets include intangible assets acquired through acquisitions as well as through direct purchases or licenses. The following table presents the amortization of purchased intangible assets, including impairment charges (in millions): Three Months Ended October 28, 2023 October 29, 2022 Amortization of purchased intangible assets: Cost of sales $ 186 $ 158 Operating expenses 67 71 Total $ 253 $ 229 The estimated future amortization expense of purchased intangible assets with finite lives as of October 28, 2023 is as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 684 2025 $ 573 2026 $ 225 2027 $ 140 2028 $ 98 Thereafter $ 10 |
Restructuring and Other Charges
Restructuring and Other Charges | 3 Months Ended |
Oct. 28, 2023 | |
Restructuring Charges [Abstract] | |
Restructuring and Other Charges | Restructuring and Other Charges In the second quarter of fiscal 2023, we announced a restructuring plan (the “Fiscal 2023 Plan”) in order to rebalance the organization and enable further investment in key priority areas, of which approximately 5% of the global workforce would be impacted. This rebalancing includes talent movement options and restructuring. Additionally, we began optimizing our real estate portfolio, aligned to the broader hybrid work strategy. In connection with the Fiscal 2023 Plan, we incurred charges of $123 million for the first quarter of fiscal 2024 and have incurred cumulative charges of $658 million to date. These aggregate pretax charges are primarily cash-based and consist of severance and other one-time termination benefits, real estate-related charges, and other costs. We have substantially completed the Fiscal 2023 Plan in the first quarter of fiscal 2024. The following table summarizes the activities related to the Fiscal 2023 Plan (in millions): FISCAL 2023 PLAN Employee Other Total Liability as of July 29, 2023 $ 166 $ 44 $ 210 Charges 103 20 123 Cash payments (99) (6) (105) Non-cash items (2) (11) (13) Liability as of October 28, 2023 $ 168 $ 47 $ 215 |
Balance Sheet and Other Details
Balance Sheet and Other Details | 3 Months Ended |
Oct. 28, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Balance Sheet and Other Details | Balance Sheet and Other Details The following tables provide details of selected balance sheet and other items (in millions, except percentages): Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents October 28, July 29, Cash and cash equivalents $ 9,602 $ 10,123 Restricted cash and restricted cash equivalents included in other current assets 378 191 Restricted cash and restricted cash equivalents included in other assets 1,125 1,313 Total $ 11,105 $ 11,627 Our restricted cash and restricted cash equivalents are funds primarily related to contractual obligations with suppliers. Inventories October 28, July 29, Raw materials $ 1,854 $ 1,685 Work in process 194 264 Finished goods 1,093 1,493 Service-related spares 188 186 Demonstration systems 13 16 Total $ 3,342 $ 3,644 Property and Equipment, Net October 28, July 29, Gross property and equipment: Land, buildings, and building and leasehold improvements $ 4,194 $ 4,229 Computer equipment and related software 682 744 Production, engineering, and other equipment 4,465 4,611 Operating lease assets 123 135 Furniture, fixtures and other 338 339 Total gross property and equipment 9,802 10,058 Less: accumulated depreciation and amortization (7,798) (7,973) Total $ 2,004 $ 2,085 Remaining Performance Obligations (RPO) October 28, July 29, Product $ 16,011 $ 15,802 Service 18,742 19,066 Total $ 34,753 $ 34,868 Short-term RPO $ 17,617 $ 17,910 Long-term RPO 17,136 16,958 Total $ 34,753 $ 34,868 Amount to be recognized as revenue over the next 12 months 51 % 51 % Deferred revenue $ 25,659 $ 25,550 Unbilled contract revenue 9,094 9,318 Total $ 34,753 $ 34,868 Unbilled contract revenue represents noncancelable contracts for which we have not invoiced, have an obligation to perform, and revenue has not yet been recognized in the financial statements. Deferred Revenue October 28, July 29, Product $ 11,689 $ 11,505 Service 13,970 14,045 Total $ 25,659 $ 25,550 Reported as: Current $ 13,812 $ 13,908 Noncurrent 11,847 11,642 Total $ 25,659 $ 25,550 Transition Tax Payable Our income tax payable associated with the one-time U.S. transition tax on accumulated earnings for foreign subsidiaries as a result of the Tax Cuts and Jobs Act is as follows (in millions): October 28, July 29, Current $ 1,364 $ 1,364 Noncurrent 4,092 4,092 Total $ 5,456 $ 5,456 |
Leases
Leases | 3 Months Ended |
Oct. 28, 2023 | |
Leases [Abstract] | |
Leases | Leases (a) Lessee Arrangements The following table presents our operating lease balances (in millions): Balance Sheet Line Item October 28, 2023 July 29, 2023 Operating lease right-of-use assets Other assets $ 997 $ 971 Operating lease liabilities Other current liabilities $ 302 $ 313 Operating lease liabilities Other long-term liabilities 741 707 Total operating lease liabilities $ 1,043 $ 1,020 The components of our lease expenses were as follows (in millions): Three Months Ended October 28, 2023 October 29, 2022 Operating lease expense $ 100 $ 96 Short-term lease expense 11 17 Variable lease expense 56 58 Total lease expense $ 167 $ 171 Supplemental information related to our operating leases is as follows (in millions): Three Months Ended October 28, 2023 October 29, 2022 Cash paid for amounts included in the measurement of lease liabilities — operating cash flows $ 88 $ 96 Right-of-use assets obtained in exchange for operating leases liabilities $ 126 $ 35 The weighted-average lease term was 4.8 years and 4.6 years as of October 28, 2023 and July 29, 2023, respectively. The weighted-average discount rate was 3.5% and 3.1% as of October 28, 2023 and July 29, 2023, respectively. The maturities of our operating leases (undiscounted) as of October 28, 2023 are as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 258 2025 278 2026 189 2027 116 2028 88 Thereafter 227 Total lease payments 1,156 Less interest (113) Total $ 1,043 (b) Lessor Arrangements Our leases primarily represent sales-type leases with terms of four years on average. We provide leasing of our equipment and complementary third-party products primarily through our channel partners and distributors, for which the income arising from these leases is recognized through interest income. Interest income was $14 million and $12 million for the first quarter of fiscal 2024 and 2023, respectively, and was included in interest income in the Consolidated Statement of Operations. The net investment of our lease receivables is measured at the commencement date as the gross lease receivable, residual value less unearned income and allowance for credit loss. For additional information, see Note 9. Future minimum lease payments on our lease receivables as of October 28, 2023 are summarized as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 433 2025 166 2026 182 2027 160 2028 126 Thereafter 45 Total 1,112 Less: Present value of lease payments (1,015) Unearned income $ 97 Actual cash collections may differ from the contractual maturities due to early customer buyouts, refinancings, or defaults. We provide financing of certain equipment through operating leases, and the amounts are included in property and equipment in the Consolidated Balance Sheets. Amounts relating to equipment on operating lease assets held by us and the associated accumulated depreciation are summarized as follows (in millions): October 28, 2023 July 29, 2023 Operating lease assets $ 123 $ 135 Accumulated depreciation (72) (78) Operating lease assets, net $ 51 $ 57 Our operating lease income was $16 million and $21 million for the first quarter of fiscal 2024 and 2023, respectively, and was included in product revenue in the Consolidated Statements of Operations. Minimum future rentals on noncancelable operating leases as of October 28, 2023 are summarized as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 18 2025 12 2026 6 Total $ 36 |
Leases | Leases (a) Lessee Arrangements The following table presents our operating lease balances (in millions): Balance Sheet Line Item October 28, 2023 July 29, 2023 Operating lease right-of-use assets Other assets $ 997 $ 971 Operating lease liabilities Other current liabilities $ 302 $ 313 Operating lease liabilities Other long-term liabilities 741 707 Total operating lease liabilities $ 1,043 $ 1,020 The components of our lease expenses were as follows (in millions): Three Months Ended October 28, 2023 October 29, 2022 Operating lease expense $ 100 $ 96 Short-term lease expense 11 17 Variable lease expense 56 58 Total lease expense $ 167 $ 171 Supplemental information related to our operating leases is as follows (in millions): Three Months Ended October 28, 2023 October 29, 2022 Cash paid for amounts included in the measurement of lease liabilities — operating cash flows $ 88 $ 96 Right-of-use assets obtained in exchange for operating leases liabilities $ 126 $ 35 The weighted-average lease term was 4.8 years and 4.6 years as of October 28, 2023 and July 29, 2023, respectively. The weighted-average discount rate was 3.5% and 3.1% as of October 28, 2023 and July 29, 2023, respectively. The maturities of our operating leases (undiscounted) as of October 28, 2023 are as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 258 2025 278 2026 189 2027 116 2028 88 Thereafter 227 Total lease payments 1,156 Less interest (113) Total $ 1,043 (b) Lessor Arrangements Our leases primarily represent sales-type leases with terms of four years on average. We provide leasing of our equipment and complementary third-party products primarily through our channel partners and distributors, for which the income arising from these leases is recognized through interest income. Interest income was $14 million and $12 million for the first quarter of fiscal 2024 and 2023, respectively, and was included in interest income in the Consolidated Statement of Operations. The net investment of our lease receivables is measured at the commencement date as the gross lease receivable, residual value less unearned income and allowance for credit loss. For additional information, see Note 9. Future minimum lease payments on our lease receivables as of October 28, 2023 are summarized as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 433 2025 166 2026 182 2027 160 2028 126 Thereafter 45 Total 1,112 Less: Present value of lease payments (1,015) Unearned income $ 97 Actual cash collections may differ from the contractual maturities due to early customer buyouts, refinancings, or defaults. We provide financing of certain equipment through operating leases, and the amounts are included in property and equipment in the Consolidated Balance Sheets. Amounts relating to equipment on operating lease assets held by us and the associated accumulated depreciation are summarized as follows (in millions): October 28, 2023 July 29, 2023 Operating lease assets $ 123 $ 135 Accumulated depreciation (72) (78) Operating lease assets, net $ 51 $ 57 Our operating lease income was $16 million and $21 million for the first quarter of fiscal 2024 and 2023, respectively, and was included in product revenue in the Consolidated Statements of Operations. Minimum future rentals on noncancelable operating leases as of October 28, 2023 are summarized as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 18 2025 12 2026 6 Total $ 36 |
Leases | Leases (a) Lessee Arrangements The following table presents our operating lease balances (in millions): Balance Sheet Line Item October 28, 2023 July 29, 2023 Operating lease right-of-use assets Other assets $ 997 $ 971 Operating lease liabilities Other current liabilities $ 302 $ 313 Operating lease liabilities Other long-term liabilities 741 707 Total operating lease liabilities $ 1,043 $ 1,020 The components of our lease expenses were as follows (in millions): Three Months Ended October 28, 2023 October 29, 2022 Operating lease expense $ 100 $ 96 Short-term lease expense 11 17 Variable lease expense 56 58 Total lease expense $ 167 $ 171 Supplemental information related to our operating leases is as follows (in millions): Three Months Ended October 28, 2023 October 29, 2022 Cash paid for amounts included in the measurement of lease liabilities — operating cash flows $ 88 $ 96 Right-of-use assets obtained in exchange for operating leases liabilities $ 126 $ 35 The weighted-average lease term was 4.8 years and 4.6 years as of October 28, 2023 and July 29, 2023, respectively. The weighted-average discount rate was 3.5% and 3.1% as of October 28, 2023 and July 29, 2023, respectively. The maturities of our operating leases (undiscounted) as of October 28, 2023 are as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 258 2025 278 2026 189 2027 116 2028 88 Thereafter 227 Total lease payments 1,156 Less interest (113) Total $ 1,043 (b) Lessor Arrangements Our leases primarily represent sales-type leases with terms of four years on average. We provide leasing of our equipment and complementary third-party products primarily through our channel partners and distributors, for which the income arising from these leases is recognized through interest income. Interest income was $14 million and $12 million for the first quarter of fiscal 2024 and 2023, respectively, and was included in interest income in the Consolidated Statement of Operations. The net investment of our lease receivables is measured at the commencement date as the gross lease receivable, residual value less unearned income and allowance for credit loss. For additional information, see Note 9. Future minimum lease payments on our lease receivables as of October 28, 2023 are summarized as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 433 2025 166 2026 182 2027 160 2028 126 Thereafter 45 Total 1,112 Less: Present value of lease payments (1,015) Unearned income $ 97 Actual cash collections may differ from the contractual maturities due to early customer buyouts, refinancings, or defaults. We provide financing of certain equipment through operating leases, and the amounts are included in property and equipment in the Consolidated Balance Sheets. Amounts relating to equipment on operating lease assets held by us and the associated accumulated depreciation are summarized as follows (in millions): October 28, 2023 July 29, 2023 Operating lease assets $ 123 $ 135 Accumulated depreciation (72) (78) Operating lease assets, net $ 51 $ 57 Our operating lease income was $16 million and $21 million for the first quarter of fiscal 2024 and 2023, respectively, and was included in product revenue in the Consolidated Statements of Operations. Minimum future rentals on noncancelable operating leases as of October 28, 2023 are summarized as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 18 2025 12 2026 6 Total $ 36 |
Financing Receivables
Financing Receivables | 3 Months Ended |
Oct. 28, 2023 | |
Receivables [Abstract] | |
Financing Receivables | Financing Receivables (a) Financing Receivables Financing receivables primarily consist of loan receivables and lease receivables. Loan receivables represent financing arrangements related to the sale of our hardware, software, and services (including technical support and advanced services), and also may include additional funding for other costs associated with network installation and integration of our products and services. Loan receivables have terms of one year to three years on average. Lease receivables represent sales-type leases resulting from the sale of Cisco’s and complementary third-party products and are typically collateralized by a security interest in the underlying assets. Lease receivables consist of arrangements with terms of four years on average. A summary of our financing receivables is presented as follows (in millions): October 28, 2023 Loan Receivables Lease Receivables Total Gross $ 5,729 $ 1,112 $ 6,841 Residual value — 68 68 Unearned income — (97) (97) Allowance for credit loss (58) (16) (74) Total, net $ 5,671 $ 1,067 $ 6,738 Reported as: Current $ 2,986 $ 428 $ 3,414 Noncurrent 2,685 639 3,324 Total, net $ 5,671 $ 1,067 $ 6,738 July 29, 2023 Loan Receivables Lease Receivables Total Gross $ 5,910 $ 1,015 $ 6,925 Residual value — 70 70 Unearned income — (88) (88) Allowance for credit loss (53) (19) (72) Total, net $ 5,857 $ 978 $ 6,835 Reported as: Current $ 2,988 $ 364 $ 3,352 Noncurrent 2,869 614 3,483 Total, net $ 5,857 $ 978 $ 6,835 (b) Credit Quality of Financing Receivables The tables below present our gross financing receivables, excluding residual value, less unearned income, categorized by our internal credit risk rating by period of origination (in millions): October 28, 2023 Fiscal Year Three Months Ended Internal Credit Risk Rating Prior July 25, 2020 July 31, 2021 July 30, 2022 July 29, 2023 October 28, 2023 Total Loan Receivables: 1 to 4 $ 40 $ 205 $ 637 $ 910 $ 1,371 $ 543 $ 3,706 5 to 6 9 109 193 327 733 513 1,884 7 and Higher 7 10 15 91 15 1 139 Total Loan Receivables $ 56 $ 324 $ 845 $ 1,328 $ 2,119 $ 1,057 $ 5,729 Lease Receivables: 1 to 4 $ 13 $ 46 $ 99 $ 82 $ 250 $ 111 $ 601 5 to 6 9 38 51 85 183 30 396 7 and Higher 1 2 3 5 5 2 18 Total Lease Receivables $ 23 $ 86 $ 153 $ 172 $ 438 $ 143 $ 1,015 Total $ 79 $ 410 $ 998 $ 1,500 $ 2,557 $ 1,200 $ 6,744 July 29, 2023 Fiscal Year Internal Credit Risk Rating Prior July 27, 2019 July 25, 2020 July 31, 2021 July 30, 2022 July 29, 2023 Total Loan Receivables: 1 to 4 $ 10 $ 53 $ 251 $ 791 $ 1,077 $ 1,784 $ 3,966 5 to 6 3 14 131 287 465 936 1,836 7 and Higher 1 7 15 17 29 39 108 Total Loan Receivables $ 14 $ 74 $ 397 $ 1,095 $ 1,571 $ 2,759 $ 5,910 Lease Receivables: 1 to 4 $ 2 $ 20 $ 57 $ 111 $ 84 $ 235 $ 509 5 to 6 2 13 44 58 87 191 395 7 and Higher — 1 2 4 5 11 23 Total Lease Receivables $ 4 $ 34 $ 103 $ 173 $ 176 $ 437 $ 927 Total $ 18 $ 108 $ 500 $ 1,268 $ 1,747 $ 3,196 $ 6,837 The following tables present the aging analysis of gross receivables as of October 28, 2023 and July 29, 2023 (in millions): DAYS PAST DUE October 28, 2023 31-60 61-90 91+ Total Current Total 120+ Still Accruing Nonaccrual Impaired Loan receivables $ 73 $ 58 $ 45 $ 176 $ 5,553 $ 5,729 $ 16 $ 12 $ 12 Lease receivables 18 12 15 45 970 1,015 5 2 2 Total $ 91 $ 70 $ 60 $ 221 $ 6,523 $ 6,744 $ 21 $ 14 $ 14 DAYS PAST DUE July 29, 2023 31-60 61-90 91+ Total Current Total 120+ Still Accruing Nonaccrual Impaired Loan receivables $ 47 $ 20 $ 37 $ 104 $ 5,806 $ 5,910 $ 17 $ 12 $ 12 Lease receivables 16 4 23 43 884 927 6 3 3 Total $ 63 $ 24 $ 60 $ 147 $ 6,690 $ 6,837 $ 23 $ 15 $ 15 Past due financing receivables are those that are 31 days or more past due according to their contractual payment terms. The data in the preceding tables is presented by contract, and the aging classification of each contract is based on the oldest outstanding receivable, and therefore past due amounts also include unbilled and current receivables within the same contract. (c) Allowance for Credit Loss Rollforward The allowances for credit loss and the related financing receivables are summarized as follows (in millions): Three Months Ended October 28, 2023 CREDIT LOSS ALLOWANCES Loan Receivables Lease Receivables Total Allowance for credit loss as of July 29, 2023 $ 53 $ 19 $ 72 Provisions (benefits) 5 (3) 2 Allowance for credit loss as of October 28, 2023 $ 58 $ 16 $ 74 Three Months Ended October 29, 2022 CREDIT LOSS ALLOWANCES Loan Receivables Lease Receivables Total Allowance for credit loss as of July 30, 2022 $ 103 $ 23 $ 126 Provisions (benefits) (1) (3) (4) Other (1) (1) (2) Allowance for credit loss as of October 29, 2022 $ 101 $ 19 $ 120 |
Investments
Investments | 3 Months Ended |
Oct. 28, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Investments | Investments (a) Summary of Available-for-Sale Debt Investments The following tables summarize our available-for-sale debt investments (in millions): October 28, 2023 Amortized Gross Gross Fair U.S. government securities $ 2,596 $ — $ (72) $ 2,524 U.S. government agency securities 421 — (6) 415 Non-U.S. government and agency securities 351 — — 351 Corporate debt securities 6,862 1 (363) 6,500 U.S. agency mortgage-backed securities 2,431 — (318) 2,113 Commercial paper 943 — — 943 Certificates of deposit 666 — — 666 Total $ 14,270 $ 1 $ (759) $ 13,512 July 29, 2023 Amortized Gross Gross Fair U.S. government securities $ 3,587 $ 1 $ (62) $ 3,526 U.S. government agency securities 428 — (5) 423 Non-U.S. government and agency securities 364 — (1) 363 Corporate debt securities 7,238 3 (327) 6,914 U.S. agency mortgage-backed securities 2,421 14 (230) 2,205 Commercial paper 1,484 — — 1,484 Certificates of deposit 677 — — 677 Total $ 16,199 $ 18 $ (625) $ 15,592 The following table presents the gross realized gains and gross realized losses related to available-for-sale debt investments (in millions): Three Months Ended October 28, 2023 October 29, 2022 Gross realized gains $ — $ — Gross realized losses (20) (6) Total $ (20) $ (6) The following tables present the breakdown of the available-for-sale debt investments with gross unrealized losses and the duration that those losses had been unrealized at October 28, 2023 and July 29, 2023 (in millions): UNREALIZED LOSSES UNREALIZED LOSSES TOTAL October 28, 2023 Fair Value Gross Fair Value Gross Fair Value Gross U.S. government securities $ 1,844 $ (38) $ 680 $ (34) $ 2,524 $ (72) U.S. government agency securities 377 (3) 38 (3) 415 (6) Non-U.S. government and agency securities 324 — — — 324 — Corporate debt securities 1,679 (29) 4,275 (304) 5,954 (333) U.S. agency mortgage-backed securities 798 (45) 1,315 (273) 2,113 (318) Commercial paper 10 — — — 10 — Certificates of deposit 10 — — — 10 — Total $ 5,042 $ (115) $ 6,308 $ (614) $ 11,350 $ (729) UNREALIZED LOSSES UNREALIZED LOSSES TOTAL July 29, 2023 Fair Value Gross Fair Value Gross Fair Value Gross U.S. government securities $ 2,394 $ (26) $ 931 $ (36) $ 3,325 $ (62) U.S. government agency securities 343 (2) 72 (3) 415 (5) Non-U.S. government and agency securities 363 (1) — — 363 (1) Corporate debt securities 1,736 (22) 4,315 (275) 6,051 (297) U.S. agency mortgage-backed securities 658 (13) 1,438 (217) 2,096 (230) Commercial paper 97 — — — 97 — Certificates of deposit 2 — — — 2 — Total $ 5,593 $ (64) $ 6,756 $ (531) $ 12,349 $ (595) The following table summarizes the maturities of our available-for-sale debt investments as of October 28, 2023 (in millions): Amortized Cost Fair Value Within 1 year $ 4,201 $ 4,152 After 1 year through 5 years 7,627 7,236 After 5 years through 10 years 9 9 After 10 years 2 2 Mortgage-backed securities with no single maturity 2,431 2,113 Total $ 14,270 $ 13,512 Actual maturities may differ from the contractual maturities because borrowers may have the right to call or prepay certain obligations. (b) Summary of Equity Investments We held marketable equity securities of $409 million and $431 million as of October 28, 2023 and July 29, 2023, respectively. We recognized a net unrealized loss of $42 million and $20 million during the first quarter of fiscal 2024 and 2023, respectively, on our marketable securities still held as of the reporting date. Our net adjustments to non-marketable equity securities measured using the measurement alternative still held was a net loss of $12 million for the first quarter of fiscal 2023. These adjustments were not material for the first quarter of fiscal 2024. We held equity interests in certain private equity funds of $0.9 billion as of each of October 28, 2023 and July 29, 2023, which are accounted for under the NAV practical expedient. In the ordinary course of business, we have investments in privately held companies and provide financing to certain customers. These privately held companies and customers are evaluated for consolidation under the variable interest or voting interest entity models. We evaluate on an ongoing basis our investments in these privately held companies and our customer financings, and have determined that as of October 28, 2023, there were no additional significant variable interest or voting interest entities required to be consolidated in our Consolidated Financial Statements. The carrying value of our investments in privately held companies was $1.8 billion as of each of October 28, 2023 and July 29, 2023. Of the total carrying value of our investments in privately held companies as of October 28, 2023, $0.9 billion of such investments are considered to be in variable interest entities which are unconsolidated. As of October 28, 2023, we have total funding commitments of $0.3 billion related to privately held investments, some of which may be based on the achievement of certain agreed-upon milestones or are required to be funded on demand. The carrying value of these investments and the additional funding commitments, collectively, represent our maximum exposure related to privately held investments. |
Fair Value
Fair Value | 3 Months Ended |
Oct. 28, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value | Fair Value (a) Assets and Liabilities Measured at Fair Value on a Recurring Basis Assets and liabilities measured at fair value on a recurring basis were as follows (in millions): OCTOBER 28, 2023 JULY 29, 2023 FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS Level 1 Level 2 Total Level 1 Level 2 Total Assets: Cash equivalents: Money market funds $ 6,650 $ — $ 6,650 $ 6,496 $ — $ 6,496 Commercial paper — 738 738 — 1,090 1,090 Certificates of deposit — 12 12 — 47 47 Corporate debt securities — 16 16 — 25 25 Available-for-sale debt investments: U.S. government securities — 2,524 2,524 — 3,526 3,526 U.S. government agency securities — 415 415 — 423 423 Non-U.S. government and agency securities — 351 351 — 363 363 Corporate debt securities — 6,500 6,500 — 6,914 6,914 U.S. agency mortgage-backed securities — 2,113 2,113 — 2,205 2,205 Commercial paper — 943 943 — 1,484 1,484 Certificates of deposit — 666 666 — 677 677 Equity investments: Marketable equity securities 409 — 409 431 — 431 Other current assets: Money market funds 375 — 375 188 — 188 Other assets: Money market funds 1,125 — 1,125 1,313 — 1,313 Derivative assets — 58 58 — 32 32 Total $ 8,559 $ 14,336 $ 22,895 $ 8,428 $ 16,786 $ 25,214 Liabilities: Derivative liabilities $ — $ 92 $ 92 $ — $ 75 $ 75 Total $ — $ 92 $ 92 $ — $ 75 $ 75 Level 1 marketable equity securities are determined by using quoted prices in active markets for identical assets. Level 2 available-for-sale debt investments are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. We use inputs such as actual trade data, benchmark yields, broker/dealer quotes, and other similar data, which are obtained from quoted market prices, independent pricing vendors, or other sources, to determine the ultimate fair value of these assets and liabilities. We use such pricing data as the primary input to make our assessments and determinations as to the ultimate valuation of our investment portfolio and have not made, during the periods presented, any material adjustments to such inputs. We are ultimately responsible for the financial statements and underlying estimates. Our derivative instruments are primarily classified as Level 2, as they are not actively traded and are valued using pricing models that use observable market inputs. We did not have any transfers between Level 1 and Level 2 fair value measurements during the periods presented. (b) Assets Measured at Fair Value on a Nonrecurring Basis Our non-marketable equity securities using the measurement alternative are adjusted to fair value on a non-recurring basis. Adjustments are made when observable transactions for identical or similar investments of the same issuer occur, or due to impairment. These securities are classified as Level 3 in the fair value hierarchy because we estimate the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs such as volatility, rights, and obligations of the securities we hold. (c) Other Fair Value Disclosures The fair value of our short-term loan receivables approximates their carrying value due to their short duration. The aggregate carrying value of our long-term loan receivables as of October 28, 2023 and July 29, 2023 was $2.7 billion and $2.9 billion, respectively. The estimated fair value of our long-term loan receivables approximates their carrying value. We use unobservable inputs in determining discounted cash flows to estimate the fair value of our long-term loan receivables, and therefore they are categorized as Level 3. As of October 28, 2023, the estimated fair value of our short-term debt |
Borrowings
Borrowings | 3 Months Ended |
Oct. 28, 2023 | |
Debt Disclosure [Abstract] | |
Borrowings | Borrowings (a) Short-Term Debt The following table summarizes our short-term debt (in millions, except percentages): October 28, 2023 July 29, 2023 Amount Effective Rate Amount Effective Rate Current portion of long-term debt $ 990 6.33 % $ 1,733 4.45 % We have a short-term debt financing program of up to $10.0 billion through the issuance of commercial paper notes. We use the proceeds from the issuance of commercial paper notes for general corporate purposes. The effective rates for the short- and long-term debt include the interest on the notes, the accretion of the discount, the issuance costs, and, if applicable, adjustments related to hedging. (b) Long-Term Debt The following table summarizes our long-term debt (in millions, except percentages): October 28, 2023 July 29, 2023 Maturity Date Amount Effective Rate Amount Effective Rate Senior notes: Fixed-rate notes: 2.20% September 20, 2023 $ — — $ 750 2.27% 3.625% March 4, 2024 1,000 6.33% 1,000 6.08% 3.50% June 15, 2025 500 6.63% 500 6.38% 2.95% February 28, 2026 750 3.01% 750 3.01% 2.50% September 20, 2026 1,500 2.55% 1,500 2.55% 5.90% February 15, 2039 2,000 6.11% 2,000 6.11% 5.50% January 15, 2040 2,000 5.67% 2,000 5.67% Total 7,750 8,500 Unaccreted discount/issuance costs (68) (68) Hedge accounting fair value adjustments (32) (41) Total $ 7,650 $ 8,391 Reported as: Current portion of long-term debt $ 990 $ 1,733 Long-term debt 6,660 6,658 Total $ 7,650 $ 8,391 We have entered into interest rate swaps in prior periods with an aggregate notional amount of $1.5 billion designated as fair value hedges of certain of our fixed-rate senior notes. These swaps convert the fixed interest rates of the fixed-rate notes to floating interest rates based on Secured Overnight Financing Rate (SOFR). The gains and losses related to changes in the fair value of the interest rate swaps substantially offset changes in the fair value of the hedged portion of the underlying debt that are attributable to the changes in market interest rates. For additional information, see Note 13. Interest is payable semiannually on each class of the senior fixed-rate notes. Each of the senior fixed-rate notes is redeemable by us at any time, subject to a make-whole premium. The senior notes rank at par with the commercial paper notes that may be issued in the future pursuant to our short-term debt financing program, as discussed above under “(a) Short-Term Debt.” As of October 28, 2023, we were in compliance with all debt covenants. As of October 28, 2023, future principal payments for long-term debt, including the current portion, are summarized as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 1,000 2025 500 2026 750 2027 1,500 Thereafter 4,000 Total $ 7,750 (c) Credit Facility On May 13, 2021, we entered into a 5-year credit agreement with certain institutional lenders that provides for a $3.0 billion unsecured revolving credit facility that is scheduled to expire on May 13, 2026. As of October 28, 2023, we were in compliance with the required interest coverage ratio and the other covenants, and we had not borrowed any funds under the credit agreement. On April 18, 2023, we entered into an amendment to the credit agreement to replace the LIBOR index with Term SOFR. |
Derivative Instruments
Derivative Instruments | 3 Months Ended |
Oct. 28, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments | Derivative Instruments (a) Summary of Derivative Instruments We use derivative instruments primarily to manage exposures to foreign currency exchange rate, interest rate, and equity price risks. Our primary objective in holding derivatives is to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates, interest rates, and equity prices. Our derivatives expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions and requiring collateral in certain cases. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored. Management does not expect material losses as a result of defaults by counterparties. The fair values of our derivative instruments and the line items on the Consolidated Balance Sheets to which they were recorded are summarized as follows (in millions): DERIVATIVE ASSETS DERIVATIVE LIABILITIES Balance Sheet Line Item October 28, July 29, Balance Sheet Line Item October 28, July 29, Derivatives designated as hedging instruments: Foreign currency derivatives Other current assets $ 38 $ 22 Other current liabilities $ — $ — Foreign currency derivatives Other assets 19 9 Other long-term liabilities — — Interest rate derivatives Other current assets — — Other current liabilities 10 17 Interest rate derivatives Other assets — — Other long-term liabilities 22 24 Total 57 31 32 41 Derivatives not designated as hedging instruments: Foreign currency derivatives Other current assets 1 1 Other current liabilities 41 25 Foreign currency derivatives Other assets — — Other long-term liabilities 19 9 Total 1 1 60 34 Total $ 58 $ 32 $ 92 $ 75 The following amounts were recorded on the Consolidated Balance Sheets related to cumulative basis adjustments for our fair value hedges (in millions): CARRYING AMOUNT OF THE HEDGED ASSETS/(LIABILITIES) CUMULATIVE AMOUNT OF FAIR VALUE HEDGING ADJUSTMENT INCLUDED IN THE CARRYING AMOUNT OF THE HEDGED ASSETS/LIABILITIES Balance Sheet Line Item of Hedged Item October 28, July 29, October 28, July 29, Short-term debt $ (990) $ (983) $ 10 $ 17 Long-term debt $ (478) $ (476) $ 22 $ 24 The effect of derivative instruments designated as fair value hedges, recognized in interest and other income (loss), net is summarized as follows (in millions): GAINS (LOSSES) FOR THE THREE MONTHS ENDED October 28, 2023 October 29, 2022 Interest rate derivatives: Hedged items $ (9) $ 39 Derivatives designated as hedging instruments 9 (39) Total $ — $ — The effect on the Consolidated Statements of Operations of derivative instruments not designated as hedges is summarized as follows (in millions): GAINS (LOSSES) FOR THE THREE MONTHS ENDED Derivatives Not Designated as Line Item in Statements of Operations October 28, October 29, Foreign currency derivatives Other income (loss), net $ (130) $ (72) Total return swaps—deferred compensation Operating expenses and other (77) (25) Equity derivatives Other income (loss), net 2 (1) Total $ (205) $ (98) The notional amounts of our outstanding derivatives are summarized as follows (in millions): October 28, July 29, Foreign currency derivatives $ 5,672 $ 5,419 Interest rate derivatives 1,500 1,500 Total return swaps—deferred compensation 783 792 Total $ 7,955 $ 7,711 (b) Offsetting of Derivative Instruments We present our derivative instruments at gross fair values in the Consolidated Balance Sheets. However, our master netting and other similar arrangements with the respective counterparties allow for net settlement under certain conditions, which are designed to reduce credit risk by permitting net settlement with the same counterparty. To further limit credit risk, we also enter into collateral security arrangements related to certain derivative instruments whereby cash is posted as collateral between the counterparties based on the fair market value of the derivative instrument. Under these collateral security arrangements, the net cash collateral provided for was $9 million and $40 million as of October 28, 2023 and July 29, 2023, respectively. (c) Foreign Currency Exchange Risk We conduct business globally in numerous currencies. Therefore, we are exposed to adverse movements in foreign currency exchange rates. To limit the exposure related to foreign currency changes, we enter into foreign currency contracts. We do not enter into such contracts for speculative purposes. We hedge forecasted foreign currency transactions related to certain revenues, operating expenses and service cost of sales with currency options and forward contracts. These currency options and forward contracts, designated as cash flow hedges, generally have maturities of less than 24 months. The derivative instrument’s gain or loss is initially reported as a component of accumulated other comprehensive income (AOCI) and subsequently reclassified into earnings when the hedged exposure affects earnings. We enter into foreign exchange forward and option contracts to reduce the short-term effects of foreign currency fluctuations on assets and liabilities such as foreign currency receivables, long-term customer financings and payables. These derivatives are not designated as hedging instruments. Gains and losses on the contracts are included in other income (loss), net, and substantially offset foreign exchange gains and losses from the remeasurement of intercompany balances, other current assets, or liabilities denominated in currencies other than the functional currency of the reporting entity. We hedge certain net investments in our foreign operations with forward contracts to reduce the effects of foreign currency fluctuations on our net investment in those foreign subsidiaries. These derivative instruments generally have maturities of up to six months. (d) Interest Rate Risk We hold interest rate swaps designated as fair value hedges related to fixed-rate senior notes that are due in fiscal 2024 through 2025. Under these interest rate swaps, we receive fixed-rate interest payments and make interest payments based on SOFR plus a fixed number of basis points. The effect of such swaps is to convert the fixed interest rates of the senior fixed-rate notes to floating interest rates based on SOFR. The gains and losses related to changes in the fair value of the interest rate swaps are included in interest expense and substantially offset changes in the fair value of the hedged portion of the underlying debt that are attributable to the changes in market interest rates. (e) Equity Price Risk We hold marketable equity securities in our portfolio that are subject to price risk. To diversify our overall portfolio, we also hold equity derivatives that are not designated as accounting hedges. The change in the fair value of each of these investment types are included in other income (loss), net. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Oct. 28, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies (a) Purchase Commitments with Contract Manufacturers and Suppliers We purchase components from a variety of suppliers and use several contract manufacturers to provide manufacturing services for our products. During the normal course of business, in order to manage manufacturing lead times and help ensure adequate component supply, we enter into agreements with contract manufacturers and suppliers that allow them to procure inventory based upon criteria as defined by us or establish the parameters defining our requirements. A significant portion of our reported purchase commitments arising from these agreements consists of firm, noncancelable, and unconditional commitments. Certain of these inventory purchase commitments with contract manufacturers and suppliers relate to arrangements to secure supply and pricing for certain product components for multi-year periods. In certain instances, these agreements allow us the option to cancel, reschedule, and adjust our requirements based on our business needs prior to firm orders being placed. The following table summarizes our inventory purchase commitments with contract manufacturers and suppliers by period (in millions): October 28, July 29, Less than 1 year $ 4,731 $ 5,270 1 to 3 years 1,646 1,783 3 to 5 years 127 200 Total $ 6,504 $ 7,253 We record a liability for firm, noncancelable, and unconditional purchase commitments for quantities in excess of our future demand forecasts consistent with the valuation of our excess and obsolete inventory. As of October 28, 2023 and July 29, 2023, the liability for these purchase commitments was $510 million and $529 million, respectively, and was included in other current liabilities. (b) Other Commitments In connection with our acquisitions, we have agreed to pay certain additional amounts contingent upon the achievement of certain agreed-upon technology, development, product, or other milestones or upon the continued employment with Cisco of certain employees of the acquired entities. The following table summarizes the compensation expense related to acquisitions (in millions): Three Months Ended October 28, 2023 October 29, 2022 Compensation expense related to acquisitions $ 49 $ 74 As of October 28, 2023, we estimated that future cash compensation expense of up to $437 million may be required to be recognized pursuant to the applicable business combination agreements. We also have certain funding commitments, primarily related to our privately held investments, some of which are based on the achievement of certain agreed-upon milestones or are required to be funded on demand. The funding commitments were $0.3 billion as of each of October 28, 2023 and July 29, 2023. (c) Product Warranties The following table summarizes the activity related to the product warranty liability (in millions): Three Months Ended October 28, October 29, Balance at beginning of period $ 329 $ 333 Provisions for warranties issued 98 97 Adjustments for pre-existing warranties 3 1 Settlements (100) (108) Balance at end of period $ 330 $ 323 We accrue for warranty costs as part of our cost of sales based on associated material product costs, labor costs for technical support staff, and associated overhead. Our products are generally covered by a warranty for periods ranging from 90 days to five years, and for some products we provide a limited lifetime warranty. (d) Financing and Other Guarantees In the ordinary course of business, we provide financing guarantees for various third-party financing arrangements extended to channel partners customers. Payments under these financing guarantee arrangements were not material for the periods presented. Channel Partner Financing Guarantees We facilitate arrangements for third-party financing extended to channel partners, consisting of revolving short-term financing, with payment terms generally ranging from 60 to 90 days. These financing arrangements facilitate the working capital requirements of the channel partners, and, in some cases, we guarantee a portion of these arrangements. The volume of channel partner financing was $8.2 billion and $7.6 billion for the first quarter of fiscal 2024 and 2023, respectively. The balance of the channel partner financing subject to guarantees was $1.5 billion and $1.7 billion as of October 28, 2023 and July 29, 2023, respectively. Financing Guarantee Summary The aggregate amounts of channel partner financing guarantees outstanding at October 28, 2023 and July 29, 2023, representing the total maximum potential future payments under financing arrangements with third parties along with the related deferred revenue, are summarized in the following table (in millions): October 28, July 29, Maximum potential future payments $ 142 $ 159 Deferred revenue (29) (34) Total $ 113 $ 125 (e) Indemnifications In the normal course of business, we have indemnification obligations to other parties, including customers, lessors, and parties to other transactions with us, with respect to certain matters. We have agreed to indemnify against losses arising from a breach of representations or covenants or out of intellectual property infringement or other claims made against certain parties. These agreements may limit the time or circumstances within which an indemnification claim can be made and the amount of the claim. It is not possible to determine the maximum potential amount for claims made under the indemnification obligations due to uncertainties in the litigation process, coordination with and contributions by other parties and the defendants in these types of cases, and the unique facts and circumstances involved in each particular case and agreement. Historically, indemnity payments made by us have not had a material effect on our Consolidated Financial Statements. In addition, we have entered into indemnification agreements with our officers and directors, and our Amended and Restated Bylaws contain similar indemnification obligations to our agents. (f) Legal Proceedings Brazil Brazilian authorities have investigated our Brazilian subsidiary and certain of its former employees, as well as a Brazilian importer of our products, and its affiliates and employees, relating to alleged evasion of import taxes and alleged improper transactions involving the subsidiary and the importer. Brazilian tax authorities have assessed claims against our Brazilian subsidiary based on a theory of joint liability with the Brazilian importer for import taxes, interest, and penalties. In addition to claims asserted by the Brazilian federal tax authorities in prior fiscal years, tax authorities from the Brazilian state of Sao Paulo have asserted similar claims on the same legal basis in prior fiscal years. The asserted claims by Brazilian federal tax authorities are for calendar years 2003 through 2007, and the asserted claims by the tax authorities from the state of Sao Paulo are for calendar years 2005 through 2007. The total asserted claims by Brazilian state and federal tax authorities aggregate to $162 million for the alleged evasion of import and other taxes, $943 million for interest, and $402 million for various penalties, all determined using an exchange rate as of October 28, 2023. We have completed a thorough review of the matters and believe the asserted claims against our Brazilian subsidiary are without merit, and we are defending the claims vigorously. While we believe there is no legal basis for the alleged liability, due to the complexities and uncertainty surrounding the judicial process in Brazil and the nature of the claims asserting joint liability with the importer, we are unable to determine the likelihood of an unfavorable outcome against our Brazilian subsidiary and are unable to reasonably estimate a range of loss, if any. We do not expect a final judicial determination for several years. Centripetal On February 13, 2018, Centripetal Networks, Inc. (“Centripetal”) asserted patent infringement claims against us in the U.S. District Court for the Eastern District of Virginia, alleging that several of our products and services infringe eleven Centripetal U.S. patents. The district court case went to trial on five asserted patents. Subsequently, on October 5, 2020, the district court issued a judgment finding validity and willful infringement of four of the asserted patents and non-infringement of the fifth patent and awarded $1.9 billion in damages and $14 million in pre-judgment interest, declined to issue an injunction but, instead, awarded Centripetal a royalty against future revenue for an initial three-year term at a 10% rate, with a minimum and maximum annual royalty of $168 million and $300 million, respectively, and for a second three-year term at a 5% rate, with a minimum and maximum annual royalty of $84 million and $150 million, respectively. We appealed and, on June 23, 2022, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) vacated the district court’s final judgment, remanded the case back to the district court to be assigned to a new judge and ordered the district court to conduct additional proceedings. The district court held a hearing on these additional proceedings over three days beginning on June 22, 2023, and a decision is pending. Prior to the hearing, on May 24, 2023, the Patent Trial and Appeal Board cancelled all claims of one of the Centripetal patents that was the subject of the hearing. On August 9, 2022, Centripetal filed a petition for writ of certiorari in the U.S. Supreme Court challenging the Federal Circuit’s decision. The Supreme Court denied Centripetal’s petition on December 5, 2022. Between April 2020 and February 2022, Centripetal filed complaints in the District Court of Dusseldorf in Germany (“German Court”), asserting a total of five patents and one utility model. Centripetal sought damages and injunctive relief in all cases. On December 10, 2021, the German Court rejected Centripetal’s complaints on two patents, and Centripetal has appealed. A hearing for a Cisco nullity action in the Federal Patent Court in Germany on one of those two patents occurred on August 1, 2022, and we are waiting for the Court’s opinion. On December 21, 2021, the German Court stayed its decision on infringement of the third patent pending a decision by the Federal Patent Court in a related nullity proceeding. On May 17, 2022, Centripetal withdrew its complaint for infringement of the German utility model. The German Court conducted a hearing on the remaining two Centripetal complaints on November 22, 2022. The German Court found no infringement on one patent and stayed the decision in the final case pending a decision by the European Patent Office in a related opposition proceeding. On July 10, 2023, Centripetal filed a complaint in the Paris Judiciary Court asserting the French counterpart of a European Patent. Centripetal seeks damages and injunctive relief in the case. Centripetal previously asserted the German counterpart of the same European Patent in Germany and the German Court rejected Centripetal’s complaint finding no infringement. Due to uncertainty surrounding patent litigation processes in the U.S. and Europe, we are unable to reasonably estimate the ultimate outcome of the litigations at this time. If we do not prevail in these litigations, we believe that any damages ultimately assessed would not have a material effect on our Consolidated Financial Statements. Ramot On June 12, 2019, Ramot at Tel Aviv University Ltd. (“Ramot”) asserted patent infringement claims against us in the U.S. District Court for the Eastern District of Texas (“E.D. Tex.”), seeking damages, including enhanced damages, and a royalty on future sales. Ramot alleges that certain Cisco optical transceiver modules and line cards infringe three patents. We challenged the validity of all three patents in the U.S. Patent and Trademark Office (“PTO”) by way of ex parte reexamination proceedings and the pending District Court case has been stayed. On July 6, 2023, the PTO issued a reexamination certificate for one of the three patents. On August 29, 2023, Cisco filed a second ex parte reexamination request against that same patent. On October 30, 2023, the PTO issued a reexamination certificate for a second of the three patents. The third asserted patent remains the subject of a pending reexamination proceeding. On February 26, 2021, Ramot asserted patent infringement claims against Acacia Communications, Inc. (“Acacia”) in the District of Delaware (“D. Del.”), seeking damages, including enhanced damages, and a royalty on future sales. Ramot alleges that certain Acacia optical transceiver modules and integrated circuits infringe two of the three patents that Ramot asserted in the E.D. Tex. case and this case is also stayed pending the reexamination proceedings referenced above. On September 28, 2021 and May 24, 2022, Cisco and Acacia filed two declaratory judgment actions of noninfringement against Ramot in D. Del on other Ramot patents in the same family as those involved in the pending cases above. Ramot is asserting counterclaims for infringement of the same patents and seeks damages, including enhanced damages, and a royalty on future sales. While we believe that we have strong non-infringement and invalidity arguments in these litigations, and that Ramot’s damages theories in such cases are not supported by prevailing law, we are unable to reasonably estimate the ultimate outcome of these litigations at this time due to uncertainties in the litigation processes. If we do not prevail in court in these litigations, we believe any damages ultimately assessed would not have a material effect on our Consolidated Financial Statements. Viasat On November 6, 2019, Viasat, Inc. (“Viasat”) filed suit against Acacia in the California Superior Court for San Diego County (“SDSC”), alleging contract and trade secret claims for certain Acacia products sold from January 1, 2019 forward (“Viasat 2019”). In May 2023, a judgment was entered against Cisco in Viasat 2019 for an amount that did not have a material effect on our Consolidated Financial Statements. Acacia filed an appeal with the California Court of Appeal. On June 9, 2020, Viasat filed another suit in SDSC alleging contract and trade secret claims for sales of additional Acacia products (“Viasat 2020”). In October 2022, an amended complaint was filed in Viasat 2020 asserting the same claims but alleging additional information. The parties have since resolved both the Viasat 2019 appeal and Viasat 2020, with dismissals entered in each matter in October 2023. The amounts paid by us to resolve these matters did not have a material effect on our Consolidated Financial Statements. Egenera On August 8, 2016, Egenera, Inc. (“Egenera”) asserted infringement claims against us in the U.S. District Court for the District of Massachusetts, alleging that Cisco’s Unified Computing System Manager infringes three patents. Egenera sought damages, including enhanced damages, and an injunction. Two of the asserted patents were dismissed, leaving Egenera’s infringement claim based on one asserted patent. On March 25, 2022, the PTO preliminarily found all of the asserted claims of the remaining patent unpatentable in ex parte reexamination proceedings. On August 15, 2022, after a jury trial for the remaining patent, the jury returned a verdict in favor of Cisco. The District Court denied Egenera’s post-trial motions, and Egenera filed an appeal to the Federal Circuit on January 13, 2023 and those proceedings are ongoing. |
Stockholders' Equity
Stockholders' Equity | 3 Months Ended |
Oct. 28, 2023 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity | Stockholders’ Equity (a) Stock Repurchase Program In September 2001, our Board of Directors authorized a stock repurchase program. As of October 28, 2023, the remaining authorized amount for stock repurchases under this program was approximately $9.7 billion with no termination date. A summary of the stock repurchase activity for fiscal 2024 and 2023 under the stock repurchase program, reported based on the trade date, is summarized as follows (in millions, except per-share amounts): Quarter Ended Shares Weighted-Average Price per Share Amount Fiscal 2024 October 28, 2023 23 $ 54.53 $ 1,252 Fiscal 2023 July 29, 2023 25 $ 50.49 $ 1,254 April 29, 2023 25 $ 49.45 $ 1,259 January 28, 2023 26 $ 47.72 $ 1,256 October 29, 2022 12 $ 43.76 $ 502 There were stock repurchases of $48 million that were pending settlement as of July 29, 2023. The purchase price for the shares of our stock repurchased is reflected as a reduction to stockholders’ equity. We are required to allocate the purchase price of the repurchased shares as (i) a reduction to retained earnings or an increase to accumulated deficit and (ii) a reduction of common stock and additional paid-in capital. (b) Dividends Declared On November 15, 2023, our Board of Directors declared a quarterly dividend of $0.39 per common share to be paid on January 24, 2024, to all stockholders of record as of the close of business on January 4, 2024. Future dividends will be subject to the approval of our Board of Directors. (c) Preferred Stock Under the terms of our Amended and Restated Certificate of Incorporation, the Board of Directors is authorized to issue preferred stock in one or more series and, in connection with the creation of such series, to fix by resolution the designation, powers (including voting powers (if any)), preferences and relative, participating, optional or other special rights, if any, of such series, and any qualifications, limitations or restrictions thereof, of the shares of such series. As of October 28, 2023, we had not issued any shares of preferred stock. |
Employee Benefit Plans
Employee Benefit Plans | 3 Months Ended |
Oct. 28, 2023 | |
Retirement Benefits [Abstract] | |
Employee Benefit Plans | Employee Benefit Plans (a) Employee Stock Incentive Plans We have one stock incentive plan: the 2005 Stock Incentive Plan (the “2005 Plan”). In addition, we have, in connection with our acquisitions of various companies, assumed the share-based awards granted under stock incentive plans of the acquired companies or issued share-based awards in replacement thereof. Share-based awards are designed to reward employees for their long-term contributions to us and provide incentives for them to remain with us. The number and frequency of share-based awards are based on competitive practices, our operating results, government regulations, and other factors. Our primary stock incentive plan is summarized as follows: The 2005 Plan provides for the granting of stock options, stock grants, stock units and stock appreciation rights (SARs), the vesting of which may be time-based or upon satisfaction of performance goals, or both, and/or other conditions. Employees (including employee directors and executive officers) and consultants of Cisco and its subsidiaries and affiliates and non-employee directors of Cisco are eligible to participate in the 2005 Plan. The 2005 Plan may be terminated by our Board of Directors at any time and for any reason, and is currently set to terminate at the 2030 Annual Meeting unless re-adopted or extended by our stockholders prior to or on such date. Under the 2005 Plan’s share reserve feature, a distinction is made between the number of shares in the reserve attributable to (i) stock options and SARs and (ii) “full value” awards (i.e., stock grants and stock units). Shares issued as stock grants, pursuant to stock units or pursuant to the settlement of dividend equivalents are counted against shares available for issuance under the 2005 Plan on a 1.5-to-1 ratio. For each share awarded as restricted stock or a restricted stock unit award under the 2005 Plan, 1.5 shares was deducted from the available share-based award balance. If awards issued under the 2005 Plan are forfeited or terminated for any reason before being exercised or settled, then the shares underlying such awards, plus the number of additional shares, if any, that counted against shares available for issuance under the 2005 Plan at the time of grant as a result of the application of the share ratio described above, will become available again for issuance under the 2005 Plan. As of October 28, 2023, 114 million shares were authorized for future grant under the 2005 Plan. (b) Employee Stock Purchase Plan We have an Employee Stock Purchase Plan under which eligible employees are offered shares through a 24-month offering period, which consists of four consecutive 6-month purchase periods. Employees may purchase a limited amount of shares of our stock at a discount of up to 15% of the lesser of the fair market value at the beginning of the offering period or the end of each 6-month purchase period. The Employee Stock Purchase Plan is scheduled to terminate on the earlier of (i) January 3, 2030 and (ii) the date on which all shares available for issuance under the Employee Stock Purchase Plan are sold pursuant to exercised purchase rights. No shares were issued under the Employee Stock Purchase Plan during each of the first quarters of fiscal 2024 and 2023. As of October 28, 2023, 88 million shares were available for issuance under the Employee Stock Purchase Plan. (c) Summary of Share-Based Compensation Expense Share-based compensation expense consists primarily of expenses for RSUs, stock purchase rights, and stock options, granted to employees or assumed from acquisitions. The following table summarizes share-based compensation expense (in millions): Three Months Ended October 28, 2023 October 29, 2022 Cost of sales—product $ 42 $ 31 Cost of sales—service 61 50 Share-based compensation expense in cost of sales 103 81 Research and development 274 204 Sales and marketing 186 153 General and administrative 90 58 Restructuring and other charges 8 — Share-based compensation expense in operating expenses 558 415 Total share-based compensation expense $ 661 $ 496 Income tax benefit for share-based compensation $ 143 $ 99 As of October 28, 2023, the total compensation cost related to unvested share-based awards not yet recognized was $4.5 billion which is expected to be recognized over approximately 2.1 years on a weighted-average basis. (d) Restricted Stock Unit Awards A summary of the restricted stock and stock unit activity, which includes time-based and performance-based or market-based RSUs, is as follows (in millions, except per-share amounts): Restricted Stock/ Weighted-Average Aggregate Fair Value Unvested balance at July 30, 2022 97 $ 46.67 Granted and assumed 72 42.08 Vested (39) 46.69 $ 1,746 Canceled/forfeited/other (8) 45.17 Unvested balance at July 29, 2023 122 $ 44.04 Granted and assumed 11 51.70 Vested (9) 44.86 $ 460 Canceled/forfeited/other (1) 41.31 Unvested balance at October 28, 2023 123 $ 44.69 |
Comprehensive Income (Loss)
Comprehensive Income (Loss) | 3 Months Ended |
Oct. 28, 2023 | |
Equity [Abstract] | |
Comprehensive Income (Loss) | Comprehensive Income (Loss) The components of AOCI, net of tax, and the other comprehensive income (loss), for the first quarter of fiscal 2024 and 2023 are summarized as follows (in millions): Net Unrealized Gains (Losses) on Available-for-Sale Investments Net Unrealized Gains (Losses) Cash Flow Hedging Instruments Cumulative Translation Adjustment and Actuarial Gains (Losses) Accumulated Other Comprehensive Income (Loss) Balance at July 29, 2023 $ (440) $ 18 $ (1,153) $ (1,575) Other comprehensive income (loss) before reclassifications (170) 38 (356) (488) (Gains) losses reclassified out of AOCI 20 (12) (1) 7 Tax benefit (expense) 36 (6) 1 31 Balance at October 28, 2023 $ (554) $ 38 $ (1,509) $ (2,025) Net Unrealized Gains (Losses) on Available-for-Sale Investments Net Unrealized Gains (Losses) Cash Flow Hedging Instruments Cumulative Translation Adjustment and Actuarial Gains (Losses) Accumulated Other Comprehensive Income (Loss) Balance at July 30, 2022 $ (379) $ 44 $ (1,287) $ (1,622) Other comprehensive income (loss) before reclassifications (329) 32 (282) (579) (Gains) losses reclassified out of AOCI 6 (19) — (13) Tax benefit (expense) 77 (3) 22 96 Balance at October 29, 2022 $ (625) $ 54 $ (1,547) $ (2,118) |
Income Taxes
Income Taxes | 3 Months Ended |
Oct. 28, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The following table provides details of income taxes (in millions, except percentages): Three Months Ended October 28, October 29, Income before provision for income taxes $ 4,442 $ 3,475 Provision for income taxes $ 804 $ 805 Effective tax rate 18.1 % 23.2 % As of October 28, 2023, we had $1.9 billion of unrecognized tax benefits, of which $1.5 billion, if recognized, would favorably impact the effective tax rate. We regularly engage in discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. We believe it is reasonably possible that certain federal, foreign, and state tax matters may be concluded in the next 12 months. Specific positions that may be resolved include issues involving transfer pricing and various other matters. |
Segment Information and Major C
Segment Information and Major Customers | 3 Months Ended |
Oct. 28, 2023 | |
Segment Reporting [Abstract] | |
Segment Information and Major Customers | Segment Information and Major Customers (a) Revenue and Gross Margin by Segment We conduct business globally and are primarily managed on a geographic basis consisting of three segments: the Americas, EMEA, and APJC. Our management makes financial decisions and allocates resources based on the information it receives from our internal management system. Sales are attributed to a segment based on the ordering location of the customer. We do not allocate research and development, sales and marketing, or general and administrative expenses to our segments in this internal management system because management does not include the information in our measurement of the performance of the operating segments. In addition, we do not allocate amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges to the gross margin for each segment because management does not include this information in our measurement of the performance of the operating segments. Summarized financial information by segment for the first quarter of fiscal 2024 and 2023, based on our internal management system and as utilized by our Chief Operating Decision Maker (“CODM”), is as follows (in millions): Three Months Ended October 28, October 29, Revenue: Americas $ 9,022 $ 7,914 EMEA 3,664 3,675 APJC 1,982 2,043 Total $ 14,668 $ 13,632 Gross margin: Americas $ 5,968 $ 4,984 EMEA 2,545 2,325 APJC 1,328 1,274 Segment total 9,841 8,582 Unallocated corporate items (284) (236) Total $ 9,557 $ 8,346 Amounts may not sum due to rounding. Revenue in the United States was $8.1 billion and $7.1 billion for the first quarter of fiscal 2024 and 2023, respectively. (b) Revenue for Groups of Similar Products and Services We design and sell Internet Protocol (IP)-based networking and other products related to the communications and IT industry and provide services associated with these products and their use. Effective in the first quarter of fiscal 2024, we began reporting our product and service revenue in the following categories: Networking, Security, Collaboration, Observability, and Services and conformed our product revenue for prior periods to the current period presentation. The following table presents revenue for groups of similar products and services (in millions): Three Months Ended October 28, October 29, Revenue: Networking $ 8,822 $ 8,031 Security 1,010 971 Collaboration 1,117 1,086 Observability 190 157 Total Product 11,139 10,245 Services 3,529 3,387 Total $ 14,668 $ 13,632 Amounts may not sum due to rounding. |
Net Income per Share
Net Income per Share | 3 Months Ended |
Oct. 28, 2023 | |
Earnings Per Share [Abstract] | |
Net Income per Share | Net Income per Share The following table presents the calculation of basic and diluted net income per share (in millions, except per-share amounts): Three Months Ended October 28, October 29, Net income $ 3,638 $ 2,670 Weighted-average shares—basic 4,057 4,108 Effect of dilutive potential common shares 30 8 Weighted-average shares—diluted 4,087 4,116 Net income per share—basic $ 0.90 $ 0.65 Net income per share—diluted $ 0.89 $ 0.65 Antidilutive employee share-based awards, excluded 16 38 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Pay vs Performance Disclosure | ||
Net income (loss) | $ 3,638 | $ 2,670 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Oct. 28, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Recent Accounting Pronounceme_2
Recent Accounting Pronouncements (Policies) | 3 Months Ended |
Oct. 28, 2023 | |
Accounting Policies [Abstract] | |
Fiscal Period | The fiscal year for Cisco Systems, Inc. (the “Company,” “Cisco,” “we,” “us,” or “our”) is the 52 or 53 weeks ending on the last Saturday in July. Fiscal 2024 and fiscal 2023 are each 52-week fiscal years. |
Basis of Presentation | The Consolidated Financial Statements include our accounts and those of our subsidiaries. All intercompany accounts and transactions have been eliminated. We conduct business globally and are primarily managed on a geographic basis in the following three geographic segments: the Americas; Europe, Middle East, and Africa (EMEA); and Asia Pacific, Japan, and China (APJC). We have prepared the accompanying financial data as of October 28, 2023 and for the first quarter of fiscal 2024 and 2023, without audit, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (GAAP) have been condensed or omitted pursuant to such rules and regulations. The July 29, 2023 Consolidated Balance Sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented not misleading. These Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended July 29, 2023. In the opinion of management, all normal recurring adjustments necessary to state fairly the consolidated balance sheet as of October 28, 2023, the results of operations, the statements of comprehensive income, the statements of cash flows and the statements of equity for the first quarter of fiscal 2024 and 2023, as applicable, have been made. The results of operations for the first quarter of fiscal 2024 are not necessarily indicative of the operating results for the full fiscal year or any future periods. Our consolidated financial statements include our accounts and investments consolidated under the voting interest model. The noncontrolling interests attributed to these investments are not presented as a separate component in the equity section of the Consolidated Balance Sheets as these amounts are not material for any of the fiscal periods presented. The share of earnings attributable to the noncontrolling interests are not presented separately in the Consolidated Statements of Operations as these amounts are not material for any of the fiscal periods presented. |
Reclassifications | Certain reclassifications have been made to the amounts in prior periods in order to conform to the current period’s presentation. We have evaluated subsequent events through the date that the financial statements were issued. |
Revenue | We enter into contracts with customers that can include various combinations of products and services which are generally distinct and accounted for as separate performance obligations. As a result, our contracts may contain multiple performance obligations. We determine whether arrangements are distinct based on whether the customer can benefit from the product or service on its own or together with other resources that are readily available and whether our commitment to transfer the product or service to the customer is separately identifiable from other obligations in the contract. We classify our hardware, perpetual software licenses, and software-as-a-service (SaaS) as distinct performance obligations. Term software licenses represent multiple obligations, which include software licenses and software maintenance. In transactions where we deliver hardware or software, we are typically the principal and we record revenue and costs of goods sold on a gross basis. We refer to our term software licenses, security software licenses, SaaS, and associated service arrangements as subscription offers. We recognize revenue upon transfer of control of promised goods or services in a contract with a customer in an amount that reflects the consideration we expect to receive in exchange for those products or services. Transfer of control occurs once the customer has the contractual right to use the product, generally upon shipment, electronic delivery (or when the software is available for download by the customer), or once title and risk of loss has transferred to the customer. Transfer of control can also occur over time for software maintenance and services as the customer receives the benefit over the contract term. Our hardware and perpetual software licenses are distinct performance obligations where revenue is recognized upfront upon transfer of control. Term software licenses include multiple performance obligations where the term licenses are recognized upfront upon transfer of control, with the associated software maintenance revenue recognized ratably over the contract term as services and software updates are provided. SaaS arrangements do not include the right for the customer to take possession of the software during the term, and therefore have one distinct performance obligation which is satisfied over time with revenue recognized ratably over the contract term as the customer consumes the services. On our product sales, we record consideration from shipping and handling on a gross basis within net product sales. We record our revenue net of any associated sales taxes. An allowance for future sales returns is established based on historical trends in product return rates. The allowance for future sales returns as of October 28, 2023 and July 29, 2023 was $37 million and $39 million, respectively, and was recorded as a reduction of our accounts receivable and revenue. Significant Judgments Revenue is allocated among these performance obligations in a manner that reflects the consideration that we expect to be entitled to for the promised goods or services based on standalone selling prices (SSP). SSP is estimated for each distinct performance obligation and judgment may be required in their determination. The best evidence of SSP is the observable price of a product or service when we sell the goods separately in similar circumstances and to similar customers. In instances where SSP is not directly observable, we determine SSP using information that may include market conditions and other observable inputs. We assess relevant contractual terms in our customer contracts to determine the transaction price. We apply judgment in identifying contractual terms and determining the transaction price as we may be required to estimate variable consideration when determining the amount of revenue to recognize. Variable consideration includes potential contractual penalties and various rebate, cooperative marketing and other incentive programs that we offer to our distributors, channel partners and customers. When determining the amount of revenue to recognize, we estimate the expected usage of these programs, applying the expected value or most likely estimate and update the estimate at each reporting period as actual utilization becomes available. We also consider the customers’ right of return in determining the transaction price, where applicable. We assess certain software licenses, such as for security software, that contain critical updates or upgrades which customers can download throughout the contract term. Without these updates or upgrades, the functionality of the software would diminish over a relatively short time period. These updates or upgrades provide the customer the full functionality of the purchased security software licenses and are required to maintain the security license’s utility as the risks and threats in the environment are rapidly changing. In these circumstances, the revenue from these software arrangements is recognized as a single performance obligation satisfied over the contract term. In addition to our product offerings, we provide a broad range of service and support options for our customers, including technical support services and advanced services. Technical support services represent the majority of these offerings which are distinct performance obligations that are satisfied over time with revenue recognized ratably over the contract term. Advanced services are distinct performance obligations that are satisfied over time with revenue recognized as services are delivered. The sales arrangements as discussed above are typically made pursuant to customer purchase orders based on master purchase or partner agreements. Cash is received based on our standard payment terms which is typically 30 days. We provide financing arrangements to customers for all of our hardware, software and service offerings. Refer to Note 9 for additional information. For these arrangements, cash is typically received over time. |
Financing Receivables | Financing receivables primarily consist of loan receivables and lease receivables. Loan receivables represent financing arrangements related to the sale of our hardware, software, and services (including technical support and advanced services), and also may include additional funding for other costs associated with network installation and integration of our products and services. Loan receivables have terms of one year to three years on average. Lease receivables represent sales-type leases resulting from the sale of Cisco’s and complementary third-party products and are typically collateralized by a security interest in the underlying assets. Lease receivables consist of arrangements with terms of four years on average. |
Fair Value of Financial Instruments | Level 1 marketable equity securities are determined by using quoted prices in active markets for identical assets. Level 2 available-for-sale debt investments are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. We use inputs such as actual trade data, benchmark yields, broker/dealer quotes, and other similar data, which are obtained from quoted market prices, independent pricing vendors, or other sources, to determine the ultimate fair value of these assets and liabilities. We use such pricing data as the primary input to make our assessments and determinations as to the ultimate valuation of our investment portfolio and have not made, during the periods presented, any material adjustments to such inputs. We are ultimately responsible for the financial statements and underlying estimates. Our derivative instruments are primarily classified as Level 2, as they are not actively traded and are valued using pricing models that use observable market inputs. We did not have any transfers between Level 1 and Level 2 fair value measurements during the periods presented.Our non-marketable equity securities using the measurement alternative are adjusted to fair value on a non-recurring basis. Adjustments are made when observable transactions for identical or similar investments of the same issuer occur, or due to impairment. These securities are classified as Level 3 in the fair value hierarchy because we estimate the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs such as volatility, rights, and obligations of the securities we hold. |
Derivatives | We use derivative instruments primarily to manage exposures to foreign currency exchange rate, interest rate, and equity price risks. Our primary objective in holding derivatives is to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates, interest rates, and equity prices. Our derivatives expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions and requiring collateral in certain cases. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored. Management does not expect material losses as a result of defaults by counterparties. |
Offsetting of Derivative Instruments | We present our derivative instruments at gross fair values in the Consolidated Balance Sheets. However, our master netting and other similar arrangements with the respective counterparties allow for net settlement under certain conditions, which are designed to reduce credit risk by permitting net settlement with the same counterparty. To further limit credit risk, we also enter into collateral security arrangements related to certain derivative instruments whereby cash is posted as collateral between the counterparties based on the fair market value of the derivative instrument. |
Hedging Derivatives | We conduct business globally in numerous currencies. Therefore, we are exposed to adverse movements in foreign currency exchange rates. To limit the exposure related to foreign currency changes, we enter into foreign currency contracts. We do not enter into such contracts for speculative purposes. We hedge forecasted foreign currency transactions related to certain revenues, operating expenses and service cost of sales with currency options and forward contracts. These currency options and forward contracts, designated as cash flow hedges, generally have maturities of less than 24 months. The derivative instrument’s gain or loss is initially reported as a component of accumulated other comprehensive income (AOCI) and subsequently reclassified into earnings when the hedged exposure affects earnings. We enter into foreign exchange forward and option contracts to reduce the short-term effects of foreign currency fluctuations on assets and liabilities such as foreign currency receivables, long-term customer financings and payables. These derivatives are not designated as hedging instruments. Gains and losses on the contracts are included in other income (loss), net, and substantially offset foreign exchange gains and losses from the remeasurement of intercompany balances, other current assets, or liabilities denominated in currencies other than the functional currency of the reporting entity. We hedge certain net investments in our foreign operations with forward contracts to reduce the effects of foreign currency fluctuations on our net investment in those foreign subsidiaries. These derivative instruments generally have maturities of up to six months. (d) Interest Rate Risk We hold interest rate swaps designated as fair value hedges related to fixed-rate senior notes that are due in fiscal 2024 through 2025. Under these interest rate swaps, we receive fixed-rate interest payments and make interest payments based on SOFR plus a fixed number of basis points. The effect of such swaps is to convert the fixed interest rates of the senior fixed-rate notes to floating interest rates based on SOFR. The gains and losses related to changes in the fair value of the interest rate swaps are included in interest expense and substantially offset changes in the fair value of the hedged portion of the underlying debt that are attributable to the changes in market interest rates. (e) Equity Price Risk |
Derivatives Not Designated as Hedges | We are also exposed to variability in compensation charges related to certain deferred compensation obligations to employees and directors. Although not designated as accounting hedges, we utilize derivatives such as total return swaps to economically hedge this exposure and offset the related compensation expense. |
Commitments and Contingencies | We purchase components from a variety of suppliers and use several contract manufacturers to provide manufacturing services for our products. During the normal course of business, in order to manage manufacturing lead times and help ensure adequate component supply, we enter into agreements with contract manufacturers and suppliers that allow them to procure inventory based upon criteria as defined by us or establish the parameters defining our requirements. A significant portion of our reported purchase commitments arising from these agreements consists of firm, noncancelable, and unconditional commitments. Certain of these inventory purchase commitments with contract manufacturers and suppliers relate to arrangements to secure supply and pricing for certain product components for multi-year periods. In certain instances, these agreements allow us the option to cancel, reschedule, and adjust our requirements based on our business needs prior to firm orders being placed.We record a liability for firm, noncancelable, and unconditional purchase commitments for quantities in excess of our future demand forecasts consistent with the valuation of our excess and obsolete inventory. |
Indemnifications | In the normal course of business, we have indemnification obligations to other parties, including customers, lessors, and parties to other transactions with us, with respect to certain matters. We have agreed to indemnify against losses arising from a breach of representations or covenants or out of intellectual property infringement or other claims made against certain parties. These agreements may limit the time or circumstances within which an indemnification claim can be made and the amount of the claim. It is not possible to determine the maximum potential amount for claims made under the indemnification obligations due to uncertainties in the litigation process, coordination with and contributions by other parties and the defendants in these types of cases, and the unique facts and circumstances involved in each particular case and agreement. Historically, indemnity payments made by us have not had a material effect on our Consolidated Financial Statements. |
Segment Information | We conduct business globally and are primarily managed on a geographic basis consisting of three segments: the Americas, EMEA, and APJC. Our management makes financial decisions and allocates resources based on the information it receives from our internal management system. Sales are attributed to a segment based on the ordering location of the customer. We do not allocate research and development, sales and marketing, or general and administrative expenses to our segments in this internal management system because management does not include the information in our measurement of the performance of the operating segments. In addition, we do not allocate amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges to the gross margin for each segment because management does not include this information in our measurement of the performance of the operating segments. |
Revenue (Tables)
Revenue (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following table presents this disaggregation of revenue (in millions): Three Months Ended October 28, October 29, Product revenue: Networking $ 8,822 $ 8,031 Security 1,010 971 Collaboration 1,117 1,086 Observability 190 157 Total Product 11,139 10,245 Services 3,529 3,387 Total $ 14,668 $ 13,632 The following table presents revenue for groups of similar products and services (in millions): Three Months Ended October 28, October 29, Revenue: Networking $ 8,822 $ 8,031 Security 1,010 971 Collaboration 1,117 1,086 Observability 190 157 Total Product 11,139 10,245 Services 3,529 3,387 Total $ 14,668 $ 13,632 |
Allowance for Credit Loss for Accounts Receivable | The allowances for credit loss for our accounts receivable are summarized as follows (in millions): Three Months Ended October 28, 2023 October 29, 2022 Allowance for credit loss at beginning of period $ 85 $ 83 Provisions (benefits) 2 11 Recoveries (write-offs), net (5) (6) Allowance for credit loss at end of period $ 82 $ 88 |
Schedule of Gross Contract Assets by Internal Risk Ratings | Gross contract assets by our internal risk ratings are summarized as follows (in millions): October 28, July 29, 1 to 4 $ 650 $ 672 5 to 6 1,015 954 7 and Higher 68 60 Total $ 1,733 $ 1,686 |
Acquisitions and Divestitures (
Acquisitions and Divestitures (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Summary of Allocation of Total Purchase Consideration | A summary of the allocation of the total purchase consideration of our completed acquisitions during the first quarter of fiscal 2024 is presented as follows (in millions): Purchase Consideration Net Tangible Assets Acquired (Liabilities Assumed) Purchased Intangible Assets Goodwill Total acquisitions $ 896 $ (73) $ 354 $ 615 |
Goodwill and Purchased Intang_2
Goodwill and Purchased Intangible Assets (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill by Reportable Segment | The following table presents the goodwill allocated to our reportable segments as of October 28, 2023 and during the first quarter of fiscal 2024 (in millions): Balance at July 29, 2023 Acquisitions Foreign Currency Translation and Other Balance at October 28, 2023 Americas $ 24,035 $ 381 $ (156) $ 24,260 EMEA 9,118 126 (59) 9,185 APJC 5,382 108 (35) 5,455 Total $ 38,535 $ 615 $ (250) $ 38,900 |
Schedule of Intangible Assets Acquired Through Business Combinations | The following table presents details of our intangible assets acquired through acquisitions completed during the first quarter of fiscal 2024 (in millions, except years): FINITE LIVES INDEFINITE LIVES TOTAL TECHNOLOGY CUSTOMER OTHER IPR&D Weighted- Amount Weighted- Amount Weighted- Amount Amount Amount Total acquisitions 4.8 $ 280 4.8 $ 58 1.0 $ 2 $ 14 $ 354 |
Schedule of Intangible Assets Acquired Through Business Combinations | The following table presents details of our intangible assets acquired through acquisitions completed during the first quarter of fiscal 2024 (in millions, except years): FINITE LIVES INDEFINITE LIVES TOTAL TECHNOLOGY CUSTOMER OTHER IPR&D Weighted- Amount Weighted- Amount Weighted- Amount Amount Amount Total acquisitions 4.8 $ 280 4.8 $ 58 1.0 $ 2 $ 14 $ 354 |
Schedule of Definite-lived Purchased Intangible Assets | The following tables present details of our purchased intangible assets (in millions): October 28, 2023 Gross Accumulated Amortization Net Purchased intangible assets with finite lives: Technology $ 3,051 $ (1,654) $ 1,397 Customer relationships 1,186 (870) 316 Other 42 (25) 17 Total purchased intangible assets with finite lives 4,279 (2,549) 1,730 In-process research and development, with indefinite lives 184 — 184 Total $ 4,463 $ (2,549) $ 1,914 July 29, 2023 Gross Accumulated Amortization Net Purchased intangible assets with finite lives: Technology $ 2,998 $ (1,691) $ 1,307 Customer relationships 1,228 (905) 323 Other 40 (22) 18 Total purchased intangible assets with finite lives 4,266 (2,618) 1,648 In-process research and development, with indefinite lives 170 — 170 Total $ 4,436 $ (2,618) $ 1,818 |
Schedule of Indefinite-lived Purchased Intangible Assets | The following tables present details of our purchased intangible assets (in millions): October 28, 2023 Gross Accumulated Amortization Net Purchased intangible assets with finite lives: Technology $ 3,051 $ (1,654) $ 1,397 Customer relationships 1,186 (870) 316 Other 42 (25) 17 Total purchased intangible assets with finite lives 4,279 (2,549) 1,730 In-process research and development, with indefinite lives 184 — 184 Total $ 4,463 $ (2,549) $ 1,914 July 29, 2023 Gross Accumulated Amortization Net Purchased intangible assets with finite lives: Technology $ 2,998 $ (1,691) $ 1,307 Customer relationships 1,228 (905) 323 Other 40 (22) 18 Total purchased intangible assets with finite lives 4,266 (2,618) 1,648 In-process research and development, with indefinite lives 170 — 170 Total $ 4,436 $ (2,618) $ 1,818 |
Schedule of Amortization of Purchased Intangible Assets | The following table presents the amortization of purchased intangible assets, including impairment charges (in millions): Three Months Ended October 28, 2023 October 29, 2022 Amortization of purchased intangible assets: Cost of sales $ 186 $ 158 Operating expenses 67 71 Total $ 253 $ 229 |
Schedule of Estimated Future Amortization Expense of Purchased Intangible Assets | The estimated future amortization expense of purchased intangible assets with finite lives as of October 28, 2023 is as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 684 2025 $ 573 2026 $ 225 2027 $ 140 2028 $ 98 Thereafter $ 10 |
Restructuring and Other Charg_2
Restructuring and Other Charges (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Restructuring Charges [Abstract] | |
Liabilities Related to Restructuring and Other Charges | The following table summarizes the activities related to the Fiscal 2023 Plan (in millions): FISCAL 2023 PLAN Employee Other Total Liability as of July 29, 2023 $ 166 $ 44 $ 210 Charges 103 20 123 Cash payments (99) (6) (105) Non-cash items (2) (11) (13) Liability as of October 28, 2023 $ 168 $ 47 $ 215 |
Balance Sheet and Other Detai_2
Balance Sheet and Other Details (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | The following tables provide details of selected balance sheet and other items (in millions, except percentages): Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents October 28, July 29, Cash and cash equivalents $ 9,602 $ 10,123 Restricted cash and restricted cash equivalents included in other current assets 378 191 Restricted cash and restricted cash equivalents included in other assets 1,125 1,313 Total $ 11,105 $ 11,627 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | The following tables provide details of selected balance sheet and other items (in millions, except percentages): Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents October 28, July 29, Cash and cash equivalents $ 9,602 $ 10,123 Restricted cash and restricted cash equivalents included in other current assets 378 191 Restricted cash and restricted cash equivalents included in other assets 1,125 1,313 Total $ 11,105 $ 11,627 |
Inventories | Inventories October 28, July 29, Raw materials $ 1,854 $ 1,685 Work in process 194 264 Finished goods 1,093 1,493 Service-related spares 188 186 Demonstration systems 13 16 Total $ 3,342 $ 3,644 |
Property and Equipment, Net | Property and Equipment, Net October 28, July 29, Gross property and equipment: Land, buildings, and building and leasehold improvements $ 4,194 $ 4,229 Computer equipment and related software 682 744 Production, engineering, and other equipment 4,465 4,611 Operating lease assets 123 135 Furniture, fixtures and other 338 339 Total gross property and equipment 9,802 10,058 Less: accumulated depreciation and amortization (7,798) (7,973) Total $ 2,004 $ 2,085 |
Remaining Performance Obligations | Remaining Performance Obligations (RPO) October 28, July 29, Product $ 16,011 $ 15,802 Service 18,742 19,066 Total $ 34,753 $ 34,868 Short-term RPO $ 17,617 $ 17,910 Long-term RPO 17,136 16,958 Total $ 34,753 $ 34,868 Amount to be recognized as revenue over the next 12 months 51 % 51 % Deferred revenue $ 25,659 $ 25,550 Unbilled contract revenue 9,094 9,318 Total $ 34,753 $ 34,868 |
Deferred Revenue | Deferred Revenue October 28, July 29, Product $ 11,689 $ 11,505 Service 13,970 14,045 Total $ 25,659 $ 25,550 Reported as: Current $ 13,812 $ 13,908 Noncurrent 11,847 11,642 Total $ 25,659 $ 25,550 |
Transition Tax Payable | Our income tax payable associated with the one-time U.S. transition tax on accumulated earnings for foreign subsidiaries as a result of the Tax Cuts and Jobs Act is as follows (in millions): October 28, July 29, Current $ 1,364 $ 1,364 Noncurrent 4,092 4,092 Total $ 5,456 $ 5,456 |
Leases (Tables)
Leases (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Leases [Abstract] | |
Operating Lease Balances | The following table presents our operating lease balances (in millions): Balance Sheet Line Item October 28, 2023 July 29, 2023 Operating lease right-of-use assets Other assets $ 997 $ 971 Operating lease liabilities Other current liabilities $ 302 $ 313 Operating lease liabilities Other long-term liabilities 741 707 Total operating lease liabilities $ 1,043 $ 1,020 |
Lease Expenses and Supplemental Information | The components of our lease expenses were as follows (in millions): Three Months Ended October 28, 2023 October 29, 2022 Operating lease expense $ 100 $ 96 Short-term lease expense 11 17 Variable lease expense 56 58 Total lease expense $ 167 $ 171 Supplemental information related to our operating leases is as follows (in millions): Three Months Ended October 28, 2023 October 29, 2022 Cash paid for amounts included in the measurement of lease liabilities — operating cash flows $ 88 $ 96 Right-of-use assets obtained in exchange for operating leases liabilities $ 126 $ 35 |
Maturities of Operating Leases | The maturities of our operating leases (undiscounted) as of October 28, 2023 are as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 258 2025 278 2026 189 2027 116 2028 88 Thereafter 227 Total lease payments 1,156 Less interest (113) Total $ 1,043 |
Future Minimum Lease Payments on Lease Receivables | Future minimum lease payments on our lease receivables as of October 28, 2023 are summarized as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 433 2025 166 2026 182 2027 160 2028 126 Thereafter 45 Total 1,112 Less: Present value of lease payments (1,015) Unearned income $ 97 |
Operating Lease Assets | Amounts relating to equipment on operating lease assets held by us and the associated accumulated depreciation are summarized as follows (in millions): October 28, 2023 July 29, 2023 Operating lease assets $ 123 $ 135 Accumulated depreciation (72) (78) Operating lease assets, net $ 51 $ 57 |
Minimum Future Rentals on Noncancelable Operating Leases | Minimum future rentals on noncancelable operating leases as of October 28, 2023 are summarized as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 18 2025 12 2026 6 Total $ 36 |
Financing Receivables (Tables)
Financing Receivables (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Receivables [Abstract] | |
Summary of Financing Receivables | A summary of our financing receivables is presented as follows (in millions): October 28, 2023 Loan Receivables Lease Receivables Total Gross $ 5,729 $ 1,112 $ 6,841 Residual value — 68 68 Unearned income — (97) (97) Allowance for credit loss (58) (16) (74) Total, net $ 5,671 $ 1,067 $ 6,738 Reported as: Current $ 2,986 $ 428 $ 3,414 Noncurrent 2,685 639 3,324 Total, net $ 5,671 $ 1,067 $ 6,738 July 29, 2023 Loan Receivables Lease Receivables Total Gross $ 5,910 $ 1,015 $ 6,925 Residual value — 70 70 Unearned income — (88) (88) Allowance for credit loss (53) (19) (72) Total, net $ 5,857 $ 978 $ 6,835 Reported as: Current $ 2,988 $ 364 $ 3,352 Noncurrent 2,869 614 3,483 Total, net $ 5,857 $ 978 $ 6,835 |
Schedule of Financing Receivables by Internal Credit Risk Rating by Period of Origination | The tables below present our gross financing receivables, excluding residual value, less unearned income, categorized by our internal credit risk rating by period of origination (in millions): October 28, 2023 Fiscal Year Three Months Ended Internal Credit Risk Rating Prior July 25, 2020 July 31, 2021 July 30, 2022 July 29, 2023 October 28, 2023 Total Loan Receivables: 1 to 4 $ 40 $ 205 $ 637 $ 910 $ 1,371 $ 543 $ 3,706 5 to 6 9 109 193 327 733 513 1,884 7 and Higher 7 10 15 91 15 1 139 Total Loan Receivables $ 56 $ 324 $ 845 $ 1,328 $ 2,119 $ 1,057 $ 5,729 Lease Receivables: 1 to 4 $ 13 $ 46 $ 99 $ 82 $ 250 $ 111 $ 601 5 to 6 9 38 51 85 183 30 396 7 and Higher 1 2 3 5 5 2 18 Total Lease Receivables $ 23 $ 86 $ 153 $ 172 $ 438 $ 143 $ 1,015 Total $ 79 $ 410 $ 998 $ 1,500 $ 2,557 $ 1,200 $ 6,744 July 29, 2023 Fiscal Year Internal Credit Risk Rating Prior July 27, 2019 July 25, 2020 July 31, 2021 July 30, 2022 July 29, 2023 Total Loan Receivables: 1 to 4 $ 10 $ 53 $ 251 $ 791 $ 1,077 $ 1,784 $ 3,966 5 to 6 3 14 131 287 465 936 1,836 7 and Higher 1 7 15 17 29 39 108 Total Loan Receivables $ 14 $ 74 $ 397 $ 1,095 $ 1,571 $ 2,759 $ 5,910 Lease Receivables: 1 to 4 $ 2 $ 20 $ 57 $ 111 $ 84 $ 235 $ 509 5 to 6 2 13 44 58 87 191 395 7 and Higher — 1 2 4 5 11 23 Total Lease Receivables $ 4 $ 34 $ 103 $ 173 $ 176 $ 437 $ 927 Total $ 18 $ 108 $ 500 $ 1,268 $ 1,747 $ 3,196 $ 6,837 |
Schedule of Aging Analysis of Financing Receivables | The following tables present the aging analysis of gross receivables as of October 28, 2023 and July 29, 2023 (in millions): DAYS PAST DUE October 28, 2023 31-60 61-90 91+ Total Current Total 120+ Still Accruing Nonaccrual Impaired Loan receivables $ 73 $ 58 $ 45 $ 176 $ 5,553 $ 5,729 $ 16 $ 12 $ 12 Lease receivables 18 12 15 45 970 1,015 5 2 2 Total $ 91 $ 70 $ 60 $ 221 $ 6,523 $ 6,744 $ 21 $ 14 $ 14 DAYS PAST DUE July 29, 2023 31-60 61-90 91+ Total Current Total 120+ Still Accruing Nonaccrual Impaired Loan receivables $ 47 $ 20 $ 37 $ 104 $ 5,806 $ 5,910 $ 17 $ 12 $ 12 Lease receivables 16 4 23 43 884 927 6 3 3 Total $ 63 $ 24 $ 60 $ 147 $ 6,690 $ 6,837 $ 23 $ 15 $ 15 |
Schedule of Allowance for Credit Loss and Related Financing Receivables | The allowances for credit loss and the related financing receivables are summarized as follows (in millions): Three Months Ended October 28, 2023 CREDIT LOSS ALLOWANCES Loan Receivables Lease Receivables Total Allowance for credit loss as of July 29, 2023 $ 53 $ 19 $ 72 Provisions (benefits) 5 (3) 2 Allowance for credit loss as of October 28, 2023 $ 58 $ 16 $ 74 Three Months Ended October 29, 2022 CREDIT LOSS ALLOWANCES Loan Receivables Lease Receivables Total Allowance for credit loss as of July 30, 2022 $ 103 $ 23 $ 126 Provisions (benefits) (1) (3) (4) Other (1) (1) (2) Allowance for credit loss as of October 29, 2022 $ 101 $ 19 $ 120 |
Investments (Tables)
Investments (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Summary of Available-for-Sale Debt Investments | The following tables summarize our available-for-sale debt investments (in millions): October 28, 2023 Amortized Gross Gross Fair U.S. government securities $ 2,596 $ — $ (72) $ 2,524 U.S. government agency securities 421 — (6) 415 Non-U.S. government and agency securities 351 — — 351 Corporate debt securities 6,862 1 (363) 6,500 U.S. agency mortgage-backed securities 2,431 — (318) 2,113 Commercial paper 943 — — 943 Certificates of deposit 666 — — 666 Total $ 14,270 $ 1 $ (759) $ 13,512 July 29, 2023 Amortized Gross Gross Fair U.S. government securities $ 3,587 $ 1 $ (62) $ 3,526 U.S. government agency securities 428 — (5) 423 Non-U.S. government and agency securities 364 — (1) 363 Corporate debt securities 7,238 3 (327) 6,914 U.S. agency mortgage-backed securities 2,421 14 (230) 2,205 Commercial paper 1,484 — — 1,484 Certificates of deposit 677 — — 677 Total $ 16,199 $ 18 $ (625) $ 15,592 |
Gross Realized Gains and Gross Realized Losses Related to Available-for-Sale Investment | The following table presents the gross realized gains and gross realized losses related to available-for-sale debt investments (in millions): Three Months Ended October 28, 2023 October 29, 2022 Gross realized gains $ — $ — Gross realized losses (20) (6) Total $ (20) $ (6) |
Available-for-Sale Investments with Gross Unrealized Losses | The following tables present the breakdown of the available-for-sale debt investments with gross unrealized losses and the duration that those losses had been unrealized at October 28, 2023 and July 29, 2023 (in millions): UNREALIZED LOSSES UNREALIZED LOSSES TOTAL October 28, 2023 Fair Value Gross Fair Value Gross Fair Value Gross U.S. government securities $ 1,844 $ (38) $ 680 $ (34) $ 2,524 $ (72) U.S. government agency securities 377 (3) 38 (3) 415 (6) Non-U.S. government and agency securities 324 — — — 324 — Corporate debt securities 1,679 (29) 4,275 (304) 5,954 (333) U.S. agency mortgage-backed securities 798 (45) 1,315 (273) 2,113 (318) Commercial paper 10 — — — 10 — Certificates of deposit 10 — — — 10 — Total $ 5,042 $ (115) $ 6,308 $ (614) $ 11,350 $ (729) UNREALIZED LOSSES UNREALIZED LOSSES TOTAL July 29, 2023 Fair Value Gross Fair Value Gross Fair Value Gross U.S. government securities $ 2,394 $ (26) $ 931 $ (36) $ 3,325 $ (62) U.S. government agency securities 343 (2) 72 (3) 415 (5) Non-U.S. government and agency securities 363 (1) — — 363 (1) Corporate debt securities 1,736 (22) 4,315 (275) 6,051 (297) U.S. agency mortgage-backed securities 658 (13) 1,438 (217) 2,096 (230) Commercial paper 97 — — — 97 — Certificates of deposit 2 — — — 2 — Total $ 5,593 $ (64) $ 6,756 $ (531) $ 12,349 $ (595) |
Maturities of Available-for-Sale Debt Investments | The following table summarizes the maturities of our available-for-sale debt investments as of October 28, 2023 (in millions): Amortized Cost Fair Value Within 1 year $ 4,201 $ 4,152 After 1 year through 5 years 7,627 7,236 After 5 years through 10 years 9 9 After 10 years 2 2 Mortgage-backed securities with no single maturity 2,431 2,113 Total $ 14,270 $ 13,512 |
Fair Value (Tables)
Fair Value (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | Assets and liabilities measured at fair value on a recurring basis were as follows (in millions): OCTOBER 28, 2023 JULY 29, 2023 FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS Level 1 Level 2 Total Level 1 Level 2 Total Assets: Cash equivalents: Money market funds $ 6,650 $ — $ 6,650 $ 6,496 $ — $ 6,496 Commercial paper — 738 738 — 1,090 1,090 Certificates of deposit — 12 12 — 47 47 Corporate debt securities — 16 16 — 25 25 Available-for-sale debt investments: U.S. government securities — 2,524 2,524 — 3,526 3,526 U.S. government agency securities — 415 415 — 423 423 Non-U.S. government and agency securities — 351 351 — 363 363 Corporate debt securities — 6,500 6,500 — 6,914 6,914 U.S. agency mortgage-backed securities — 2,113 2,113 — 2,205 2,205 Commercial paper — 943 943 — 1,484 1,484 Certificates of deposit — 666 666 — 677 677 Equity investments: Marketable equity securities 409 — 409 431 — 431 Other current assets: Money market funds 375 — 375 188 — 188 Other assets: Money market funds 1,125 — 1,125 1,313 — 1,313 Derivative assets — 58 58 — 32 32 Total $ 8,559 $ 14,336 $ 22,895 $ 8,428 $ 16,786 $ 25,214 Liabilities: Derivative liabilities $ — $ 92 $ 92 $ — $ 75 $ 75 Total $ — $ 92 $ 92 $ — $ 75 $ 75 |
Borrowings (Tables)
Borrowings (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Short-Term Debt | The following table summarizes our short-term debt (in millions, except percentages): October 28, 2023 July 29, 2023 Amount Effective Rate Amount Effective Rate Current portion of long-term debt $ 990 6.33 % $ 1,733 4.45 % |
Schedule of Long-Term Debt | The following table summarizes our long-term debt (in millions, except percentages): October 28, 2023 July 29, 2023 Maturity Date Amount Effective Rate Amount Effective Rate Senior notes: Fixed-rate notes: 2.20% September 20, 2023 $ — — $ 750 2.27% 3.625% March 4, 2024 1,000 6.33% 1,000 6.08% 3.50% June 15, 2025 500 6.63% 500 6.38% 2.95% February 28, 2026 750 3.01% 750 3.01% 2.50% September 20, 2026 1,500 2.55% 1,500 2.55% 5.90% February 15, 2039 2,000 6.11% 2,000 6.11% 5.50% January 15, 2040 2,000 5.67% 2,000 5.67% Total 7,750 8,500 Unaccreted discount/issuance costs (68) (68) Hedge accounting fair value adjustments (32) (41) Total $ 7,650 $ 8,391 Reported as: Current portion of long-term debt $ 990 $ 1,733 Long-term debt 6,660 6,658 Total $ 7,650 $ 8,391 |
Schedule of Future Principal Payments for Long-Term Debt | As of October 28, 2023, future principal payments for long-term debt, including the current portion, are summarized as follows (in millions): Fiscal Year Amount 2024 (remaining nine months) $ 1,000 2025 500 2026 750 2027 1,500 Thereafter 4,000 Total $ 7,750 |
Derivative Instruments (Tables)
Derivative Instruments (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Fair Value of Derivative Instruments by Balance Sheet Line Item | The fair values of our derivative instruments and the line items on the Consolidated Balance Sheets to which they were recorded are summarized as follows (in millions): DERIVATIVE ASSETS DERIVATIVE LIABILITIES Balance Sheet Line Item October 28, July 29, Balance Sheet Line Item October 28, July 29, Derivatives designated as hedging instruments: Foreign currency derivatives Other current assets $ 38 $ 22 Other current liabilities $ — $ — Foreign currency derivatives Other assets 19 9 Other long-term liabilities — — Interest rate derivatives Other current assets — — Other current liabilities 10 17 Interest rate derivatives Other assets — — Other long-term liabilities 22 24 Total 57 31 32 41 Derivatives not designated as hedging instruments: Foreign currency derivatives Other current assets 1 1 Other current liabilities 41 25 Foreign currency derivatives Other assets — — Other long-term liabilities 19 9 Total 1 1 60 34 Total $ 58 $ 32 $ 92 $ 75 |
Cumulative Basis Adjustment For Fair Value Hedges | The following amounts were recorded on the Consolidated Balance Sheets related to cumulative basis adjustments for our fair value hedges (in millions): CARRYING AMOUNT OF THE HEDGED ASSETS/(LIABILITIES) CUMULATIVE AMOUNT OF FAIR VALUE HEDGING ADJUSTMENT INCLUDED IN THE CARRYING AMOUNT OF THE HEDGED ASSETS/LIABILITIES Balance Sheet Line Item of Hedged Item October 28, July 29, October 28, July 29, Short-term debt $ (990) $ (983) $ 10 $ 17 Long-term debt $ (478) $ (476) $ 22 $ 24 |
Effect on Derivative Instruments Designated as Fair Value Hedges | The effect of derivative instruments designated as fair value hedges, recognized in interest and other income (loss), net is summarized as follows (in millions): GAINS (LOSSES) FOR THE THREE MONTHS ENDED October 28, 2023 October 29, 2022 Interest rate derivatives: Hedged items $ (9) $ 39 Derivatives designated as hedging instruments 9 (39) Total $ — $ — |
Effect of Derivative Instruments Not Designated as Fair Value Hedges on Consolidated Statements of Operations | The effect on the Consolidated Statements of Operations of derivative instruments not designated as hedges is summarized as follows (in millions): GAINS (LOSSES) FOR THE THREE MONTHS ENDED Derivatives Not Designated as Line Item in Statements of Operations October 28, October 29, Foreign currency derivatives Other income (loss), net $ (130) $ (72) Total return swaps—deferred compensation Operating expenses and other (77) (25) Equity derivatives Other income (loss), net 2 (1) Total $ (205) $ (98) |
Schedule of Notional Amounts of Derivatives Outstanding | The notional amounts of our outstanding derivatives are summarized as follows (in millions): October 28, July 29, Foreign currency derivatives $ 5,672 $ 5,419 Interest rate derivatives 1,500 1,500 Total return swaps—deferred compensation 783 792 Total $ 7,955 $ 7,711 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Purchase Commitments with Contract Manufacturers and Suppliers | The following table summarizes our inventory purchase commitments with contract manufacturers and suppliers by period (in millions): October 28, July 29, Less than 1 year $ 4,731 $ 5,270 1 to 3 years 1,646 1,783 3 to 5 years 127 200 Total $ 6,504 $ 7,253 |
Compensation Expense Related to Business Acquisitions | The following table summarizes the compensation expense related to acquisitions (in millions): Three Months Ended October 28, 2023 October 29, 2022 Compensation expense related to acquisitions $ 49 $ 74 |
Schedule of Product Warranty Liability | The following table summarizes the activity related to the product warranty liability (in millions): Three Months Ended October 28, October 29, Balance at beginning of period $ 329 $ 333 Provisions for warranties issued 98 97 Adjustments for pre-existing warranties 3 1 Settlements (100) (108) Balance at end of period $ 330 $ 323 |
Schedule of Guarantor Obligations | The aggregate amounts of channel partner financing guarantees outstanding at October 28, 2023 and July 29, 2023, representing the total maximum potential future payments under financing arrangements with third parties along with the related deferred revenue, are summarized in the following table (in millions): October 28, July 29, Maximum potential future payments $ 142 $ 159 Deferred revenue (29) (34) Total $ 113 $ 125 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Stockholders' Equity Note [Abstract] | |
Stock Repurchase Program | A summary of the stock repurchase activity for fiscal 2024 and 2023 under the stock repurchase program, reported based on the trade date, is summarized as follows (in millions, except per-share amounts): Quarter Ended Shares Weighted-Average Price per Share Amount Fiscal 2024 October 28, 2023 23 $ 54.53 $ 1,252 Fiscal 2023 July 29, 2023 25 $ 50.49 $ 1,254 April 29, 2023 25 $ 49.45 $ 1,259 January 28, 2023 26 $ 47.72 $ 1,256 October 29, 2022 12 $ 43.76 $ 502 |
Employee Benefit Plans (Tables)
Employee Benefit Plans (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Retirement Benefits [Abstract] | |
Summary of Share-Based Compensation Expense | The following table summarizes share-based compensation expense (in millions): Three Months Ended October 28, 2023 October 29, 2022 Cost of sales—product $ 42 $ 31 Cost of sales—service 61 50 Share-based compensation expense in cost of sales 103 81 Research and development 274 204 Sales and marketing 186 153 General and administrative 90 58 Restructuring and other charges 8 — Share-based compensation expense in operating expenses 558 415 Total share-based compensation expense $ 661 $ 496 Income tax benefit for share-based compensation $ 143 $ 99 |
Summary of Restricted Stock and Stock Unit Activity | A summary of the restricted stock and stock unit activity, which includes time-based and performance-based or market-based RSUs, is as follows (in millions, except per-share amounts): Restricted Stock/ Weighted-Average Aggregate Fair Value Unvested balance at July 30, 2022 97 $ 46.67 Granted and assumed 72 42.08 Vested (39) 46.69 $ 1,746 Canceled/forfeited/other (8) 45.17 Unvested balance at July 29, 2023 122 $ 44.04 Granted and assumed 11 51.70 Vested (9) 44.86 $ 460 Canceled/forfeited/other (1) 41.31 Unvested balance at October 28, 2023 123 $ 44.69 |
Comprehensive Income (Loss) (Ta
Comprehensive Income (Loss) (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Equity [Abstract] | |
Components of AOCI, Net of Tax | The components of AOCI, net of tax, and the other comprehensive income (loss), for the first quarter of fiscal 2024 and 2023 are summarized as follows (in millions): Net Unrealized Gains (Losses) on Available-for-Sale Investments Net Unrealized Gains (Losses) Cash Flow Hedging Instruments Cumulative Translation Adjustment and Actuarial Gains (Losses) Accumulated Other Comprehensive Income (Loss) Balance at July 29, 2023 $ (440) $ 18 $ (1,153) $ (1,575) Other comprehensive income (loss) before reclassifications (170) 38 (356) (488) (Gains) losses reclassified out of AOCI 20 (12) (1) 7 Tax benefit (expense) 36 (6) 1 31 Balance at October 28, 2023 $ (554) $ 38 $ (1,509) $ (2,025) Net Unrealized Gains (Losses) on Available-for-Sale Investments Net Unrealized Gains (Losses) Cash Flow Hedging Instruments Cumulative Translation Adjustment and Actuarial Gains (Losses) Accumulated Other Comprehensive Income (Loss) Balance at July 30, 2022 $ (379) $ 44 $ (1,287) $ (1,622) Other comprehensive income (loss) before reclassifications (329) 32 (282) (579) (Gains) losses reclassified out of AOCI 6 (19) — (13) Tax benefit (expense) 77 (3) 22 96 Balance at October 29, 2022 $ (625) $ 54 $ (1,547) $ (2,118) |
Income Taxes (Tables)
Income Taxes (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Tax Provision | The following table provides details of income taxes (in millions, except percentages): Three Months Ended October 28, October 29, Income before provision for income taxes $ 4,442 $ 3,475 Provision for income taxes $ 804 $ 805 Effective tax rate 18.1 % 23.2 % |
Segment Information and Major_2
Segment Information and Major Customers (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Segment Reporting [Abstract] | |
Reportable Segments | Summarized financial information by segment for the first quarter of fiscal 2024 and 2023, based on our internal management system and as utilized by our Chief Operating Decision Maker (“CODM”), is as follows (in millions): Three Months Ended October 28, October 29, Revenue: Americas $ 9,022 $ 7,914 EMEA 3,664 3,675 APJC 1,982 2,043 Total $ 14,668 $ 13,632 Gross margin: Americas $ 5,968 $ 4,984 EMEA 2,545 2,325 APJC 1,328 1,274 Segment total 9,841 8,582 Unallocated corporate items (284) (236) Total $ 9,557 $ 8,346 |
Net Sales for Groups of Similar Products and Services | The following table presents this disaggregation of revenue (in millions): Three Months Ended October 28, October 29, Product revenue: Networking $ 8,822 $ 8,031 Security 1,010 971 Collaboration 1,117 1,086 Observability 190 157 Total Product 11,139 10,245 Services 3,529 3,387 Total $ 14,668 $ 13,632 The following table presents revenue for groups of similar products and services (in millions): Three Months Ended October 28, October 29, Revenue: Networking $ 8,822 $ 8,031 Security 1,010 971 Collaboration 1,117 1,086 Observability 190 157 Total Product 11,139 10,245 Services 3,529 3,387 Total $ 14,668 $ 13,632 |
Net Income per Share (Tables)
Net Income per Share (Tables) | 3 Months Ended |
Oct. 28, 2023 | |
Earnings Per Share [Abstract] | |
Calculation of Basic and Diluted Net Income per Share | The following table presents the calculation of basic and diluted net income per share (in millions, except per-share amounts): Three Months Ended October 28, October 29, Net income $ 3,638 $ 2,670 Weighted-average shares—basic 4,057 4,108 Effect of dilutive potential common shares 30 8 Weighted-average shares—diluted 4,087 4,116 Net income per share—basic $ 0.90 $ 0.65 Net income per share—diluted $ 0.89 $ 0.65 Antidilutive employee share-based awards, excluded 16 38 |
Organization and Basis of Pre_2
Organization and Basis of Presentation (Details) | 3 Months Ended |
Oct. 28, 2023 segment | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of geographic segments | 3 |
Revenue - Additional Informatio
Revenue - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Oct. 28, 2023 | Oct. 29, 2022 | Jul. 29, 2023 | |
Disaggregation of Revenue [Line Items] | |||
Allowance for future sales returns | $ 37 | $ 39 | |
Payment terms | 30 days | ||
Accounts receivable, net | $ 4,833 | 5,854 | |
Deferred revenue | 25,659 | 25,550 | |
Revenue recognized | 4,700 | ||
Total deferred sales commissions | 1,200 | 1,100 | |
Amortization of sales commissions, expense | 158 | $ 176 | |
Software and Service Agreements | |||
Disaggregation of Revenue [Line Items] | |||
Contract assets, net of allowances | $ 1,700 | $ 1,600 |
Revenue - Disaggregation of Rev
Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Disaggregation of Revenue [Line Items] | ||
Revenue | $ 14,668 | $ 13,632 |
Product | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 11,139 | 10,245 |
Networking | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 8,822 | 8,031 |
Security | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 1,010 | 971 |
Collaboration | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 1,117 | 1,086 |
Observability | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | 190 | 157 |
Services | ||
Disaggregation of Revenue [Line Items] | ||
Revenue | $ 3,529 | $ 3,387 |
Revenue - Allowance for Account
Revenue - Allowance for Accounts Receivable (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | ||
Allowance for credit loss at beginning of period | $ 85 | $ 83 |
Provisions (benefits) | 2 | 11 |
Recoveries (write-offs), net | (5) | (6) |
Allowance for credit loss at end of period | $ 82 | $ 88 |
Revenue - Schedule of Internal
Revenue - Schedule of Internal Risk Ratings for Contract Assets (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Contract asset, gross | $ 1,733 | $ 1,686 |
1 to 4 | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Contract asset, gross | 650 | 672 |
5 to 6 | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Contract asset, gross | 1,015 | 954 |
7 and Higher | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Contract asset, gross | $ 68 | $ 60 |
Acquisitions and Divestitures -
Acquisitions and Divestitures - Summary of Allocation of Total Purchase Consideration (Details) $ in Millions | 3 Months Ended |
Oct. 28, 2023 USD ($) | |
Business Combination and Asset Acquisition [Abstract] | |
Purchase Consideration | $ 896 |
Net Tangible Assets Acquired (Liabilities Assumed) | (73) |
Purchased Intangible Assets | 354 |
Goodwill | $ 615 |
Acquisitions and Divestitures_2
Acquisitions and Divestitures - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | ||
Oct. 28, 2023 | Oct. 29, 2022 | Apr. 27, 2024 | |
Business Acquisition [Line Items] | |||
Acquired cash and cash equivalents | $ 16 | ||
Splunk | Forecast | |||
Business Acquisition [Line Items] | |||
Acqusition price (in dollars per share) | $ 157 | ||
Equity value of acquisition | $ 28,000 | ||
General and administrative | |||
Business Acquisition [Line Items] | |||
Transaction costs | $ 31 | $ 2 |
Goodwill and Purchased Intang_3
Goodwill and Purchased Intangible Assets - Schedule of Goodwill by Reportable Segments (Details) $ in Millions | 3 Months Ended |
Oct. 28, 2023 USD ($) | |
Goodwill [Roll Forward] | |
Beginning Balance | $ 38,535 |
Acquisitions | 615 |
Foreign Currency Translation and Other | (250) |
Ending Balance | 38,900 |
Americas | |
Goodwill [Roll Forward] | |
Beginning Balance | 24,035 |
Acquisitions | 381 |
Foreign Currency Translation and Other | (156) |
Ending Balance | 24,260 |
EMEA | |
Goodwill [Roll Forward] | |
Beginning Balance | 9,118 |
Acquisitions | 126 |
Foreign Currency Translation and Other | (59) |
Ending Balance | 9,185 |
APJC | |
Goodwill [Roll Forward] | |
Beginning Balance | 5,382 |
Acquisitions | 108 |
Foreign Currency Translation and Other | (35) |
Ending Balance | $ 5,455 |
Goodwill and Purchased Intang_4
Goodwill and Purchased Intangible Assets - Schedule of Intangible Assets Acquired Through Business Combinations (Details) $ in Millions | 3 Months Ended |
Oct. 28, 2023 USD ($) | |
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Acquired Through Business Combinations [Line Items] | |
Total, amount | $ 354 |
In-process research and development | |
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Acquired Through Business Combinations [Line Items] | |
Indefinite-lived intangible assets acquired | $ 14 |
TECHNOLOGY | |
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Acquired Through Business Combinations [Line Items] | |
Weighted- Average Useful Life (in Years) | 4 years 9 months 18 days |
Finite lived assets acquired | $ 280 |
CUSTOMER RELATIONSHIPS | |
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Acquired Through Business Combinations [Line Items] | |
Weighted- Average Useful Life (in Years) | 4 years 9 months 18 days |
Finite lived assets acquired | $ 58 |
OTHER | |
Schedule Of Finite Lived And Indefinite Lived Intangible Assets Acquired Through Business Combinations [Line Items] | |
Weighted- Average Useful Life (in Years) | 1 year |
Finite lived assets acquired | $ 2 |
Goodwill and Purchased Intang_5
Goodwill and Purchased Intangible Assets - Schedule of Purchased Intangible Assets With Finite and Indefinite Lives (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Purchased intangible assets with finite lives: | ||
Gross | $ 4,279 | $ 4,266 |
Accumulated Amortization | (2,549) | (2,618) |
Total purchased intangible assets with finite lives, net | 1,730 | 1,648 |
In-process research and development, with indefinite lives | 184 | 170 |
Total finite and indefinite lives intangible assets, gross | 4,463 | 4,436 |
Total finite and indefinite lives intangible assets, net | 1,914 | 1,818 |
Technology | ||
Purchased intangible assets with finite lives: | ||
Gross | 3,051 | 2,998 |
Accumulated Amortization | (1,654) | (1,691) |
Total purchased intangible assets with finite lives, net | 1,397 | 1,307 |
Customer relationships | ||
Purchased intangible assets with finite lives: | ||
Gross | 1,186 | 1,228 |
Accumulated Amortization | (870) | (905) |
Total purchased intangible assets with finite lives, net | 316 | 323 |
Other | ||
Purchased intangible assets with finite lives: | ||
Gross | 42 | 40 |
Accumulated Amortization | (25) | (22) |
Total purchased intangible assets with finite lives, net | $ 17 | $ 18 |
Goodwill and Purchased Intang_6
Goodwill and Purchased Intangible Assets - Schedule of Amortization of Purchased Intangible Assets (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Amortization of purchased intangible assets | $ 67 | $ 71 |
Total | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Amortization of purchased intangible assets | 253 | 229 |
Cost of sales | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Amortization of purchased intangible assets | 186 | 158 |
Operating expenses | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Amortization of purchased intangible assets | $ 67 | $ 71 |
Goodwill and Purchased Intang_7
Goodwill and Purchased Intangible Assets - Schedule of Estimated Future Amortization Expense of Purchased Intangible Assets (Details) $ in Millions | Oct. 28, 2023 USD ($) |
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | |
2024 (remaining nine months) | $ 684 |
2025 | 573 |
2026 | 225 |
2027 | 140 |
2028 | 98 |
Thereafter | $ 10 |
Restructuring and Other Charg_3
Restructuring and Other Charges - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Oct. 28, 2023 | Jan. 28, 2023 | Oct. 29, 2022 | |
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other charges | $ 123 | $ (2) | |
FISCAL 2023 PLAN | |||
Restructuring Cost and Reserve [Line Items] | |||
Percentage of global workforce impacted by restructure | 5% | ||
Restructuring and other charges | 123 | ||
Cumulative restructuring charges incurred | $ 658 |
Restructuring and Other Charg_4
Restructuring and Other Charges - Schedule of Activities Related to Restructuring and Other Charges (Details) $ in Millions | 3 Months Ended |
Oct. 28, 2023 USD ($) | |
Restructuring Reserve [Roll Forward] | |
Liability, beginning of period | $ 210 |
Charges | 123 |
Cash payments | (105) |
Non-cash items | (13) |
Liability, end of period | 215 |
FISCAL 2023 PLAN | Employee Severance | |
Restructuring Reserve [Roll Forward] | |
Liability, beginning of period | 166 |
Charges | 103 |
Cash payments | (99) |
Non-cash items | (2) |
Liability, end of period | 168 |
FISCAL 2023 PLAN | Other | |
Restructuring Reserve [Roll Forward] | |
Liability, beginning of period | 44 |
Charges | 20 |
Cash payments | (6) |
Non-cash items | (11) |
Liability, end of period | $ 47 |
Balance Sheet and Other Detai_3
Balance Sheet and Other Details - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 | Oct. 29, 2022 | Jul. 30, 2022 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||
Cash and cash equivalents | $ 9,602 | $ 10,123 | ||
Restricted cash and restricted cash equivalents included in other current assets | 378 | 191 | ||
Restricted cash and restricted cash equivalents included in other assets | 1,125 | 1,313 | ||
Total | $ 11,105 | $ 11,627 | $ 8,792 | $ 8,579 |
Balance Sheet and Other Detai_4
Balance Sheet and Other Details - Inventories (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Raw materials | $ 1,854 | $ 1,685 |
Work in process | 194 | 264 |
Finished goods | 1,093 | 1,493 |
Service-related spares | 188 | 186 |
Demonstration systems | 13 | 16 |
Total | $ 3,342 | $ 3,644 |
Balance Sheet and Other Detai_5
Balance Sheet and Other Details - Property and Equipment, Net (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Property, Plant and Equipment [Line Items] | ||
Operating lease assets | $ 123 | $ 135 |
Total gross property and equipment | 9,802 | 10,058 |
Less: accumulated depreciation and amortization | (7,798) | (7,973) |
Total | 2,004 | 2,085 |
Land, buildings, and building and leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Gross property and equipment, excluding operating lease assets | 4,194 | 4,229 |
Computer equipment and related software | ||
Property, Plant and Equipment [Line Items] | ||
Gross property and equipment, excluding operating lease assets | 682 | 744 |
Production, engineering, and other equipment | ||
Property, Plant and Equipment [Line Items] | ||
Gross property and equipment, excluding operating lease assets | 4,465 | 4,611 |
Furniture, fixtures and other | ||
Property, Plant and Equipment [Line Items] | ||
Gross property and equipment, excluding operating lease assets | $ 338 | $ 339 |
Balance Sheet and Other Detai_6
Balance Sheet and Other Details - Remaining Performance Obligations (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation | $ 34,753 | $ 34,868 |
Deferred revenue | 25,659 | 25,550 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-30 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation | $ 17,910 | |
Period for amount to be recognized as revenue | 12 months | |
Amount to be recognized as revenue over the next 12 months | 51% | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-29 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation | $ 17,617 | |
Period for amount to be recognized as revenue | 12 months | |
Amount to be recognized as revenue over the next 12 months | 51% | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-28 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation | $ 16,958 | |
Period for amount to be recognized as revenue | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-27 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation | $ 17,136 | |
Period for amount to be recognized as revenue | ||
Unbilled contract revenue | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation | $ 9,094 | $ 9,318 |
Product | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation | 16,011 | 15,802 |
Deferred revenue | 11,689 | 11,505 |
Service | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation | 18,742 | 19,066 |
Deferred revenue | $ 13,970 | $ 14,045 |
Balance Sheet and Other Detai_7
Balance Sheet and Other Details - Deferred Revenue (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Disaggregation of Revenue [Line Items] | ||
Total deferred revenue | $ 25,659 | $ 25,550 |
Current | 13,812 | 13,908 |
Noncurrent | 11,847 | 11,642 |
Product | ||
Disaggregation of Revenue [Line Items] | ||
Total deferred revenue | 11,689 | 11,505 |
Service | ||
Disaggregation of Revenue [Line Items] | ||
Total deferred revenue | $ 13,970 | $ 14,045 |
Balance Sheet and Other Detai_8
Balance Sheet and Other Details - Transition Tax Payable (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Current | $ 1,364 | $ 1,364 |
Noncurrent | 4,092 | 4,092 |
Total | $ 5,456 | $ 5,456 |
Leases - Operating Lease Balanc
Leases - Operating Lease Balances (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Leases [Abstract] | ||
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Other assets | Other assets |
Operating lease right-of-use assets | $ 997 | $ 971 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Other current liabilities | Other current liabilities |
Operating lease liabilities | $ 302 | $ 313 |
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other long-term liabilities | Other long-term liabilities |
Operating lease liabilities | $ 741 | $ 707 |
Total operating lease liabilities | $ 1,043 | $ 1,020 |
Leases - Lease Expenses (Detail
Leases - Lease Expenses (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Leases [Abstract] | ||
Operating lease expense | $ 100 | $ 96 |
Short-term lease expense | 11 | 17 |
Variable lease expense | 56 | 58 |
Total lease expense | $ 167 | $ 171 |
Leases - Supplemental Informati
Leases - Supplemental Information (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Leases [Abstract] | ||
Cash paid for amounts included in the measurement of lease liabilities — operating cash flows | $ 88 | $ 96 |
Right-of-use assets obtained in exchange for operating leases liabilities | $ 126 | $ 35 |
Leases - Additional Information
Leases - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Oct. 28, 2023 | Oct. 29, 2022 | Jul. 29, 2023 | |
Leases [Abstract] | |||
Weighted-average remaining lease term (in years) | 4 years 9 months 18 days | 4 years 7 months 6 days | |
Weighted-average discount rate | 3.50% | 3.10% | |
Sales-type lease terms, on average | 4 years | ||
Interest income, lease receivables | $ 14 | $ 12 | |
Operating lease income | $ 16 | $ 21 |
Leases - Lessee, Maturities of
Leases - Lessee, Maturities of Operating Leases (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Leases [Abstract] | ||
2024 (remaining nine months) | $ 258 | |
2025 | 278 | |
2026 | 189 | |
2027 | 116 | |
2028 | 88 | |
Thereafter | 227 | |
Total lease payments | 1,156 | |
Less interest | (113) | |
Total | $ 1,043 | $ 1,020 |
Leases - Lessor, Future Minimum
Leases - Lessor, Future Minimum Lease Payments on Lease Receivables (Details) $ in Millions | Oct. 28, 2023 USD ($) |
Leases [Abstract] | |
2024 (remaining nine months) | $ 433 |
2025 | 166 |
2026 | 182 |
2027 | 160 |
2028 | 126 |
Thereafter | 45 |
Total | 1,112 |
Less: Present value of lease payments | (1,015) |
Unearned income | $ 97 |
Leases - Operating Lease Assets
Leases - Operating Lease Assets (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Leases [Abstract] | ||
Operating lease assets | $ 123 | $ 135 |
Accumulated depreciation | (72) | (78) |
Operating lease assets, net | $ 51 | $ 57 |
Leases - Lessor, Minimum Future
Leases - Lessor, Minimum Future Rentals on Noncancelable operating leases (Details) $ in Millions | Oct. 28, 2023 USD ($) |
Leases [Abstract] | |
2024 (remaining nine months) | $ 18 |
2025 | 12 |
2026 | 6 |
Total | $ 36 |
Financing Receivables - Additio
Financing Receivables - Additional Information (Details) | 3 Months Ended |
Oct. 28, 2023 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Lease receivables terms, on average | 4 years |
Threshold for past due receivables | 31 days |
Minimum | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Loan receivables term, on average | 1 year |
Maximum | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |
Loan receivables term, on average | 3 years |
Financing Receivables - Schedul
Financing Receivables - Schedule of Financing Receivables (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 | Oct. 29, 2022 | Jul. 30, 2022 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross | $ 6,841 | $ 6,925 | ||
Residual value | 68 | 70 | ||
Unearned income | (97) | (88) | ||
Allowance for credit loss | (74) | (72) | $ (120) | $ (126) |
Total, net | 6,738 | 6,835 | ||
Current | 3,414 | 3,352 | ||
Noncurrent | 3,324 | 3,483 | ||
Loan Receivables | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross | 5,729 | 5,910 | ||
Unearned income | 0 | 0 | ||
Allowance for credit loss | (58) | (53) | (101) | (103) |
Total, net | 5,671 | 5,857 | ||
Current | 2,986 | 2,988 | ||
Noncurrent | 2,685 | 2,869 | ||
Lease Receivables | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Gross | 1,112 | 1,015 | ||
Residual value | 68 | 70 | ||
Unearned income | (97) | (88) | ||
Allowance for credit loss | (16) | (19) | $ (19) | $ (23) |
Total, net | 1,067 | 978 | ||
Current | 428 | 364 | ||
Noncurrent | $ 639 | $ 614 |
Financing Receivables - Sched_2
Financing Receivables - Schedule of Financing Receivables Categorized by Internal Credit Risk Rating (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Origination year - Prior | $ 79 | $ 18 |
Origination year - Fiscal Year 2019/2018 | 410 | 108 |
Origination year - Fiscal Year 2020/2019 | 998 | 500 |
Origination year - Fiscal Year 2021/2020 | 1,500 | 1,268 |
Origination year - Fiscal Year 2022/2021 | 2,557 | 1,747 |
Origination year - Fiscal Year 2023/2022 | 1,200 | 3,196 |
Gross | 6,744 | 6,837 |
Loan Receivables | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Origination year - Prior | 56 | 14 |
Origination year - Fiscal Year 2019/2018 | 324 | 74 |
Origination year - Fiscal Year 2020/2019 | 845 | 397 |
Origination year - Fiscal Year 2021/2020 | 1,328 | 1,095 |
Origination year - Fiscal Year 2022/2021 | 2,119 | 1,571 |
Origination year - Fiscal Year 2023/2022 | 1,057 | 2,759 |
Gross | 5,729 | 5,910 |
Lease Receivables | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Origination year - Prior | 23 | 4 |
Origination year - Fiscal Year 2019/2018 | 86 | 34 |
Origination year - Fiscal Year 2020/2019 | 153 | 103 |
Origination year - Fiscal Year 2021/2020 | 172 | 173 |
Origination year - Fiscal Year 2022/2021 | 438 | 176 |
Origination year - Fiscal Year 2023/2022 | 143 | 437 |
Gross | 1,015 | 927 |
1 to 4 | Loan Receivables | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Origination year - Prior | 40 | 10 |
Origination year - Fiscal Year 2019/2018 | 205 | 53 |
Origination year - Fiscal Year 2020/2019 | 637 | 251 |
Origination year - Fiscal Year 2021/2020 | 910 | 791 |
Origination year - Fiscal Year 2022/2021 | 1,371 | 1,077 |
Origination year - Fiscal Year 2023/2022 | 543 | 1,784 |
Gross | 3,706 | 3,966 |
1 to 4 | Lease Receivables | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Origination year - Prior | 13 | 2 |
Origination year - Fiscal Year 2019/2018 | 46 | 20 |
Origination year - Fiscal Year 2020/2019 | 99 | 57 |
Origination year - Fiscal Year 2021/2020 | 82 | 111 |
Origination year - Fiscal Year 2022/2021 | 250 | 84 |
Origination year - Fiscal Year 2023/2022 | 111 | 235 |
Gross | 601 | 509 |
5 to 6 | Loan Receivables | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Origination year - Prior | 9 | 3 |
Origination year - Fiscal Year 2019/2018 | 109 | 14 |
Origination year - Fiscal Year 2020/2019 | 193 | 131 |
Origination year - Fiscal Year 2021/2020 | 327 | 287 |
Origination year - Fiscal Year 2022/2021 | 733 | 465 |
Origination year - Fiscal Year 2023/2022 | 513 | 936 |
Gross | 1,884 | 1,836 |
5 to 6 | Lease Receivables | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Origination year - Prior | 9 | 2 |
Origination year - Fiscal Year 2019/2018 | 38 | 13 |
Origination year - Fiscal Year 2020/2019 | 51 | 44 |
Origination year - Fiscal Year 2021/2020 | 85 | 58 |
Origination year - Fiscal Year 2022/2021 | 183 | 87 |
Origination year - Fiscal Year 2023/2022 | 30 | 191 |
Gross | 396 | 395 |
7 and Higher | Loan Receivables | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Origination year - Prior | 7 | 1 |
Origination year - Fiscal Year 2019/2018 | 10 | 7 |
Origination year - Fiscal Year 2020/2019 | 15 | 15 |
Origination year - Fiscal Year 2021/2020 | 91 | 17 |
Origination year - Fiscal Year 2022/2021 | 15 | 29 |
Origination year - Fiscal Year 2023/2022 | 1 | 39 |
Gross | 139 | 108 |
7 and Higher | Lease Receivables | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Origination year - Prior | 1 | 0 |
Origination year - Fiscal Year 2019/2018 | 2 | 1 |
Origination year - Fiscal Year 2020/2019 | 3 | 2 |
Origination year - Fiscal Year 2021/2020 | 5 | 4 |
Origination year - Fiscal Year 2022/2021 | 5 | 5 |
Origination year - Fiscal Year 2023/2022 | 2 | 11 |
Gross | $ 18 | $ 23 |
Financing Receivables - Sched_3
Financing Receivables - Schedule of Aging Analysis of Financing Receivables (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | $ 6,744 | $ 6,837 |
120+ Still Accruing | 21 | 23 |
Nonaccrual Financing Receivables | 14 | 15 |
Impaired Financing Receivables | 14 | 15 |
Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 221 | 147 |
31-60 | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 91 | 63 |
61-90 | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 70 | 24 |
91+ | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 60 | 60 |
Current | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 6,523 | 6,690 |
Loan Receivables | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 5,729 | 5,910 |
120+ Still Accruing | 16 | 17 |
Nonaccrual Financing Receivables | 12 | 12 |
Impaired Financing Receivables | 12 | 12 |
Loan Receivables | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 176 | 104 |
Loan Receivables | 31-60 | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 73 | 47 |
Loan Receivables | 61-90 | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 58 | 20 |
Loan Receivables | 91+ | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 45 | 37 |
Loan Receivables | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 5,553 | 5,806 |
Lease Receivables | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 1,015 | 927 |
120+ Still Accruing | 5 | 6 |
Nonaccrual Financing Receivables | 2 | 3 |
Impaired Financing Receivables | 2 | 3 |
Lease Receivables | Total Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 45 | 43 |
Lease Receivables | 31-60 | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 18 | 16 |
Lease Receivables | 61-90 | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 12 | 4 |
Lease Receivables | 91+ | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | 15 | 23 |
Lease Receivables | Current | ||
Financing Receivable, Past Due [Line Items] | ||
Gross Financing Receivables | $ 970 | $ 884 |
Financing Receivables - Summary
Financing Receivables - Summary of Allowances for Credit Loss and Related Financing Receivables (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | ||
Allowance for credit loss, beginning of period | $ 72 | $ 126 |
Provisions (benefits) | 2 | (4) |
Other | (2) | |
Allowance for credit loss, end of period | 74 | 120 |
Loan Receivables | ||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | ||
Allowance for credit loss, beginning of period | 53 | 103 |
Provisions (benefits) | 5 | (1) |
Other | (1) | |
Allowance for credit loss, end of period | 58 | 101 |
Lease Receivables | ||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | ||
Allowance for credit loss, beginning of period | 19 | 23 |
Provisions (benefits) | (3) | (3) |
Other | (1) | |
Allowance for credit loss, end of period | $ 16 | $ 19 |
Investments - Summary of Availa
Investments - Summary of Available-for-Sale Debt Investments (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 14,270 | $ 16,199 |
Gross Unrealized Gains | 1 | 18 |
Gross Unrealized and Credit Losses | (759) | (625) |
Fair Value | 13,512 | 15,592 |
U.S. government securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 2,596 | 3,587 |
Gross Unrealized Gains | 0 | 1 |
Gross Unrealized and Credit Losses | (72) | (62) |
Fair Value | 2,524 | 3,526 |
U.S. government agency securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 421 | 428 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized and Credit Losses | (6) | (5) |
Fair Value | 415 | 423 |
Non-U.S. government and agency securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 351 | 364 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized and Credit Losses | 0 | (1) |
Fair Value | 351 | 363 |
Corporate debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 6,862 | 7,238 |
Gross Unrealized Gains | 1 | 3 |
Gross Unrealized and Credit Losses | (363) | (327) |
Fair Value | 6,500 | 6,914 |
U.S. agency mortgage-backed securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 2,431 | 2,421 |
Gross Unrealized Gains | 0 | 14 |
Gross Unrealized and Credit Losses | (318) | (230) |
Fair Value | 2,113 | 2,205 |
Commercial paper | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 943 | 1,484 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized and Credit Losses | 0 | 0 |
Fair Value | 943 | 1,484 |
Certificates of deposit | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 666 | 677 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized and Credit Losses | 0 | 0 |
Fair Value | $ 666 | $ 677 |
Investments - Gross Realized Ga
Investments - Gross Realized Gains and Gross Realized Losses Related to Available-for-Sale Investment (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Investments, Debt and Equity Securities [Abstract] | ||
Gross realized gains | $ 0 | $ 0 |
Gross realized losses | (20) | (6) |
Total | $ (20) | $ (6) |
Investments - Available-for-Sal
Investments - Available-for-Sale Investments With Gross Unrealized Losses (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Debt Securities, Available-for-sale [Line Items] | ||
UNREALIZED LOSSES LESS THAN 12 MONTHS, Fair Value | $ 5,042 | $ 5,593 |
UNREALIZED LOSSES LESS THAN 12 MONTHS, Gross Unrealized Losses | (115) | (64) |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Fair Value | 6,308 | 6,756 |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Gross Unrealized Losses | (614) | (531) |
TOTAL, Fair Value | 11,350 | 12,349 |
TOTAL, Gross Unrealized Losses | (729) | (595) |
U.S. government securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
UNREALIZED LOSSES LESS THAN 12 MONTHS, Fair Value | 1,844 | 2,394 |
UNREALIZED LOSSES LESS THAN 12 MONTHS, Gross Unrealized Losses | (38) | (26) |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Fair Value | 680 | 931 |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Gross Unrealized Losses | (34) | (36) |
TOTAL, Fair Value | 2,524 | 3,325 |
TOTAL, Gross Unrealized Losses | (72) | (62) |
U.S. government agency securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
UNREALIZED LOSSES LESS THAN 12 MONTHS, Fair Value | 377 | 343 |
UNREALIZED LOSSES LESS THAN 12 MONTHS, Gross Unrealized Losses | (3) | (2) |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Fair Value | 38 | 72 |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Gross Unrealized Losses | (3) | (3) |
TOTAL, Fair Value | 415 | 415 |
TOTAL, Gross Unrealized Losses | (6) | (5) |
Non-U.S. government and agency securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
UNREALIZED LOSSES LESS THAN 12 MONTHS, Fair Value | 324 | 363 |
UNREALIZED LOSSES LESS THAN 12 MONTHS, Gross Unrealized Losses | 0 | (1) |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Fair Value | 0 | 0 |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Gross Unrealized Losses | 0 | 0 |
TOTAL, Fair Value | 324 | 363 |
TOTAL, Gross Unrealized Losses | 0 | (1) |
Corporate debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
UNREALIZED LOSSES LESS THAN 12 MONTHS, Fair Value | 1,679 | 1,736 |
UNREALIZED LOSSES LESS THAN 12 MONTHS, Gross Unrealized Losses | (29) | (22) |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Fair Value | 4,275 | 4,315 |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Gross Unrealized Losses | (304) | (275) |
TOTAL, Fair Value | 5,954 | 6,051 |
TOTAL, Gross Unrealized Losses | (333) | (297) |
U.S. agency mortgage-backed securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
UNREALIZED LOSSES LESS THAN 12 MONTHS, Fair Value | 798 | 658 |
UNREALIZED LOSSES LESS THAN 12 MONTHS, Gross Unrealized Losses | (45) | (13) |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Fair Value | 1,315 | 1,438 |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Gross Unrealized Losses | (273) | (217) |
TOTAL, Fair Value | 2,113 | 2,096 |
TOTAL, Gross Unrealized Losses | (318) | (230) |
Commercial paper | ||
Debt Securities, Available-for-sale [Line Items] | ||
UNREALIZED LOSSES LESS THAN 12 MONTHS, Fair Value | 10 | 97 |
UNREALIZED LOSSES LESS THAN 12 MONTHS, Gross Unrealized Losses | 0 | 0 |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Fair Value | 0 | 0 |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Gross Unrealized Losses | 0 | 0 |
TOTAL, Fair Value | 10 | 97 |
TOTAL, Gross Unrealized Losses | 0 | 0 |
Certificates of deposit | ||
Debt Securities, Available-for-sale [Line Items] | ||
UNREALIZED LOSSES LESS THAN 12 MONTHS, Fair Value | 10 | 2 |
UNREALIZED LOSSES LESS THAN 12 MONTHS, Gross Unrealized Losses | 0 | 0 |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Fair Value | 0 | 0 |
UNREALIZED LOSSES 12 MONTHS OR GREATER, Gross Unrealized Losses | 0 | 0 |
TOTAL, Fair Value | 10 | 2 |
TOTAL, Gross Unrealized Losses | $ 0 | $ 0 |
Investments - Maturities of Ava
Investments - Maturities of Available-for-Sale Debt Investments (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Amortized Cost | ||
Within 1 year | $ 4,201 | |
After 1 year through 5 years | 7,627 | |
After 5 years through 10 years | 9 | |
After 10 years | 2 | |
Mortgage-backed securities with no single maturity | 2,431 | |
Amortized Cost | 14,270 | $ 16,199 |
Fair Value | ||
Within 1 year | 4,152 | |
After 1 year through 5 years | 7,236 | |
After 5 years through 10 years | 9 | |
After 10 years | 2 | |
Mortgage-backed securities with no single maturity | 2,113 | |
Fair Value | $ 13,512 | $ 15,592 |
Investments - Additional Inform
Investments - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Oct. 28, 2023 | Oct. 29, 2022 | Jul. 29, 2023 | |
Schedule of Investments [Line Items] | |||
Marketable equity securities | $ 409 | $ 431 | |
Unrealized loss | 42 | $ 20 | |
Net loss on non-marketable equity securities measured using the measurement alternative | 0 | $ 12 | |
Investments in privately held companies | 1,800 | 1,800 | |
Funding commitments | 300 | ||
Variable Interest Entity, Not Primary Beneficiary | |||
Schedule of Investments [Line Items] | |||
Investments in privately held companies | 900 | ||
Private equity funds | Fair value measured at NAV per share | |||
Schedule of Investments [Line Items] | |||
Equity interests held in certain private equity funds | $ 900 | $ 900 |
Fair Value - Assets and Liabili
Fair Value - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Assets: | ||
Available-for-sale debt investments: | $ 13,512 | $ 15,592 |
Marketable equity securities | 409 | 431 |
Derivative assets | 58 | 32 |
Total | 22,895 | 25,214 |
Liabilities: | ||
Derivative liabilities | 92 | 75 |
Total | 92 | 75 |
Money market funds | ||
Assets: | ||
Other current assets: | 375 | 188 |
Other assets: | 1,125 | 1,313 |
U.S. government securities | ||
Assets: | ||
Available-for-sale debt investments: | 2,524 | 3,526 |
U.S. government agency securities | ||
Assets: | ||
Available-for-sale debt investments: | 415 | 423 |
Non-U.S. government and agency securities | ||
Assets: | ||
Available-for-sale debt investments: | 351 | 363 |
Corporate debt securities | ||
Assets: | ||
Available-for-sale debt investments: | 6,500 | 6,914 |
U.S. agency mortgage-backed securities | ||
Assets: | ||
Available-for-sale debt investments: | 2,113 | 2,205 |
Commercial paper | ||
Assets: | ||
Available-for-sale debt investments: | 943 | 1,484 |
Certificates of deposit | ||
Assets: | ||
Available-for-sale debt investments: | 666 | 677 |
Money market funds | ||
Assets: | ||
Cash equivalents: | 6,650 | 6,496 |
Commercial paper | ||
Assets: | ||
Cash equivalents: | 738 | 1,090 |
Certificates of deposit | ||
Assets: | ||
Cash equivalents: | 12 | 47 |
Corporate debt securities | ||
Assets: | ||
Cash equivalents: | 16 | 25 |
Level 1 | ||
Assets: | ||
Marketable equity securities | 409 | 431 |
Derivative assets | 0 | 0 |
Total | 8,559 | 8,428 |
Liabilities: | ||
Derivative liabilities | 0 | 0 |
Total | 0 | 0 |
Level 1 | Money market funds | ||
Assets: | ||
Other current assets: | 375 | 188 |
Other assets: | 1,125 | 1,313 |
Level 1 | U.S. government securities | ||
Assets: | ||
Available-for-sale debt investments: | 0 | 0 |
Level 1 | U.S. government agency securities | ||
Assets: | ||
Available-for-sale debt investments: | 0 | 0 |
Level 1 | Non-U.S. government and agency securities | ||
Assets: | ||
Available-for-sale debt investments: | 0 | 0 |
Level 1 | Corporate debt securities | ||
Assets: | ||
Available-for-sale debt investments: | 0 | 0 |
Level 1 | U.S. agency mortgage-backed securities | ||
Assets: | ||
Available-for-sale debt investments: | 0 | 0 |
Level 1 | Commercial paper | ||
Assets: | ||
Available-for-sale debt investments: | 0 | 0 |
Level 1 | Certificates of deposit | ||
Assets: | ||
Available-for-sale debt investments: | 0 | 0 |
Level 1 | Money market funds | ||
Assets: | ||
Cash equivalents: | 6,650 | 6,496 |
Level 1 | Commercial paper | ||
Assets: | ||
Cash equivalents: | 0 | 0 |
Level 1 | Certificates of deposit | ||
Assets: | ||
Cash equivalents: | 0 | 0 |
Level 1 | Corporate debt securities | ||
Assets: | ||
Cash equivalents: | 0 | 0 |
Level 2 | ||
Assets: | ||
Marketable equity securities | 0 | 0 |
Derivative assets | 58 | 32 |
Total | 14,336 | 16,786 |
Liabilities: | ||
Derivative liabilities | 92 | 75 |
Total | 92 | 75 |
Level 2 | Money market funds | ||
Assets: | ||
Other current assets: | 0 | 0 |
Other assets: | 0 | 0 |
Level 2 | U.S. government securities | ||
Assets: | ||
Available-for-sale debt investments: | 2,524 | 3,526 |
Level 2 | U.S. government agency securities | ||
Assets: | ||
Available-for-sale debt investments: | 415 | 423 |
Level 2 | Non-U.S. government and agency securities | ||
Assets: | ||
Available-for-sale debt investments: | 351 | 363 |
Level 2 | Corporate debt securities | ||
Assets: | ||
Available-for-sale debt investments: | 6,500 | 6,914 |
Level 2 | U.S. agency mortgage-backed securities | ||
Assets: | ||
Available-for-sale debt investments: | 2,113 | 2,205 |
Level 2 | Commercial paper | ||
Assets: | ||
Available-for-sale debt investments: | 943 | 1,484 |
Level 2 | Certificates of deposit | ||
Assets: | ||
Available-for-sale debt investments: | 666 | 677 |
Level 2 | Money market funds | ||
Assets: | ||
Cash equivalents: | 0 | 0 |
Level 2 | Commercial paper | ||
Assets: | ||
Cash equivalents: | 738 | 1,090 |
Level 2 | Certificates of deposit | ||
Assets: | ||
Cash equivalents: | 12 | 47 |
Level 2 | Corporate debt securities | ||
Assets: | ||
Cash equivalents: | $ 16 | $ 25 |
Fair Value - Additional Informa
Fair Value - Additional Information (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Long-term financing receivables, carrying value | $ 3,324 | $ 3,483 |
Borrowings, carrying value | 7,650 | 8,391 |
Loan Receivables | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Long-term financing receivables, carrying value | 2,685 | 2,869 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Borrowings, fair value | $ 7,500 | $ 8,700 |
Borrowings - Schedule of Short-
Borrowings - Schedule of Short-Term Debt (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Short-term Debt [Line Items] | ||
Current portion of long-term debt | $ 990 | $ 1,733 |
Senior Notes | ||
Short-term Debt [Line Items] | ||
Current portion of long-term debt | $ 990 | $ 1,733 |
Effective Rate | 6.33% | 4.45% |
Borrowings - Additional Informa
Borrowings - Additional Information (Details) | May 13, 2021 USD ($) extension_option | Oct. 28, 2023 USD ($) | Jul. 29, 2023 USD ($) |
Debt Instrument [Line Items] | |||
Derivative, notional amount | $ 7,955,000,000 | $ 7,711,000,000 | |
Revolving credit facility | Unsecured facility | |||
Debt Instrument [Line Items] | |||
Credit facility, term | 5 years | ||
Maximum borrowing capacity | $ 3,000,000,000 | ||
Line of credit facility, amount outstanding | 0 | ||
Additional credit facility upon agreement (up to) | $ 2,000,000,000 | ||
Number of extension options | extension_option | 2 | ||
Revolving credit facility | Unsecured facility | U.S. dollars | Term Secured Overnight Financing Rate (SOFR) | |||
Debt Instrument [Line Items] | |||
Credit spread adjustment | 0.10% | ||
Basis spread on variable rate | 1% | ||
Revolving credit facility | Unsecured facility | U.S. dollars | Federal Funds rate | |||
Debt Instrument [Line Items] | |||
Basis spread on variable rate | 0.50% | ||
Revolving credit facility | Unsecured facility | Pound Sterling | Minimum | |||
Debt Instrument [Line Items] | |||
Interest rate | 0% | ||
Interest rate swaps | Fair Value Hedge | Derivatives designated as hedging instruments | |||
Debt Instrument [Line Items] | |||
Derivative, notional amount | 1,500,000,000 | ||
Commercial paper | |||
Debt Instrument [Line Items] | |||
Commercial paper, maximum borrowing limit (up to) | $ 10,000,000,000 |
Borrowings - Schedule of Long-T
Borrowings - Schedule of Long-Term Debt (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Debt Instrument [Line Items] | ||
Total | $ 7,750 | $ 8,500 |
Unaccreted discount/issuance costs | (68) | (68) |
Hedge accounting fair value adjustments | (32) | (41) |
Total | 7,650 | 8,391 |
Current portion of long-term debt | 990 | 1,733 |
Long-term debt | $ 6,660 | 6,658 |
Fixed-Rate Notes, 2.20%, Due September 20, 2023 | ||
Debt Instrument [Line Items] | ||
Interest rate, stated percentage | 2.20% | |
Amount | $ 0 | $ 750 |
Effective Rate | 0% | 2.27% |
Fixed-Rate Notes, 3.625%, Due March 4, 2024 | ||
Debt Instrument [Line Items] | ||
Interest rate, stated percentage | 3.625% | |
Amount | $ 1,000 | $ 1,000 |
Effective Rate | 6.33% | 6.08% |
Fixed-Rate Notes, 3.50%, Due June 15, 2025 | ||
Debt Instrument [Line Items] | ||
Interest rate, stated percentage | 3.50% | |
Amount | $ 500 | $ 500 |
Effective Rate | 6.63% | 6.38% |
Fixed-Rate Notes, 2.95%, Due February 28, 2026 | ||
Debt Instrument [Line Items] | ||
Interest rate, stated percentage | 2.95% | |
Amount | $ 750 | $ 750 |
Effective Rate | 3.01% | 3.01% |
Fixed-Rate Notes, 2.50%, Due September 20, 2026 | ||
Debt Instrument [Line Items] | ||
Interest rate, stated percentage | 2.50% | |
Amount | $ 1,500 | $ 1,500 |
Effective Rate | 2.55% | 2.55% |
Fixed-Rate Notes, 5.90%, Due February 15, 2039 | ||
Debt Instrument [Line Items] | ||
Interest rate, stated percentage | 5.90% | |
Amount | $ 2,000 | $ 2,000 |
Effective Rate | 6.11% | 6.11% |
Fixed-Rate Notes, 5.50%, Due January 15, 2040 | ||
Debt Instrument [Line Items] | ||
Interest rate, stated percentage | 5.50% | |
Amount | $ 2,000 | $ 2,000 |
Effective Rate | 5.67% | 5.67% |
Borrowings - Schedule of Future
Borrowings - Schedule of Future Principal Payments for Long-Term Debt (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Debt Disclosure [Abstract] | ||
2024 (remaining nine months) | $ 1,000 | |
2025 | 500 | |
2026 | 750 | |
2027 | 1,500 | |
Thereafter | 4,000 | |
Total | $ 7,750 | $ 8,500 |
Derivative Instruments - Fair V
Derivative Instruments - Fair Value of Derivatives Derivative Instruments by Balance Sheet Line Item (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Derivative [Line Items] | ||
DERIVATIVE ASSETS | $ 58 | $ 32 |
DERIVATIVE LIABILITIES | 92 | 75 |
Derivatives designated as hedging instruments: | ||
Derivative [Line Items] | ||
DERIVATIVE ASSETS | 57 | 31 |
DERIVATIVE LIABILITIES | 32 | 41 |
Derivatives designated as hedging instruments: | Foreign currency derivatives | Other current assets | ||
Derivative [Line Items] | ||
DERIVATIVE ASSETS | 38 | 22 |
Derivatives designated as hedging instruments: | Foreign currency derivatives | Other assets | ||
Derivative [Line Items] | ||
DERIVATIVE ASSETS | 19 | 9 |
Derivatives designated as hedging instruments: | Foreign currency derivatives | Other current liabilities | ||
Derivative [Line Items] | ||
DERIVATIVE LIABILITIES | 0 | 0 |
Derivatives designated as hedging instruments: | Foreign currency derivatives | Other long-term liabilities | ||
Derivative [Line Items] | ||
DERIVATIVE LIABILITIES | 0 | 0 |
Derivatives designated as hedging instruments: | Interest rate derivatives | Other current assets | ||
Derivative [Line Items] | ||
DERIVATIVE ASSETS | 0 | 0 |
Derivatives designated as hedging instruments: | Interest rate derivatives | Other assets | ||
Derivative [Line Items] | ||
DERIVATIVE ASSETS | 0 | 0 |
Derivatives designated as hedging instruments: | Interest rate derivatives | Other current liabilities | ||
Derivative [Line Items] | ||
DERIVATIVE LIABILITIES | 10 | 17 |
Derivatives designated as hedging instruments: | Interest rate derivatives | Other long-term liabilities | ||
Derivative [Line Items] | ||
DERIVATIVE LIABILITIES | 22 | 24 |
Derivatives not designated as hedging instruments: | ||
Derivative [Line Items] | ||
DERIVATIVE ASSETS | 1 | 1 |
DERIVATIVE LIABILITIES | 60 | 34 |
Derivatives not designated as hedging instruments: | Foreign currency derivatives | Other current assets | ||
Derivative [Line Items] | ||
DERIVATIVE ASSETS | 1 | 1 |
Derivatives not designated as hedging instruments: | Foreign currency derivatives | Other assets | ||
Derivative [Line Items] | ||
DERIVATIVE ASSETS | 0 | 0 |
Derivatives not designated as hedging instruments: | Foreign currency derivatives | Other current liabilities | ||
Derivative [Line Items] | ||
DERIVATIVE LIABILITIES | 41 | 25 |
Derivatives not designated as hedging instruments: | Foreign currency derivatives | Other long-term liabilities | ||
Derivative [Line Items] | ||
DERIVATIVE LIABILITIES | $ 19 | $ 9 |
Derivative Instruments - Cumula
Derivative Instruments - Cumulative Basis Adjustments For Fair Value Hedges (Details) - Derivatives designated as hedging instruments: - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Short-term debt | ||
Derivative [Line Items] | ||
CARRYING AMOUNT OF THE HEDGED ASSETS/(LIABILITIES) | $ (990) | $ (983) |
CUMULATIVE AMOUNT OF FAIR VALUE HEDGING ADJUSTMENT INCLUDED IN THE CARRYING AMOUNT OF THE HEDGED ASSETS/LIABILITIES | 10 | 17 |
Long-term debt | ||
Derivative [Line Items] | ||
CARRYING AMOUNT OF THE HEDGED ASSETS/(LIABILITIES) | (478) | (476) |
CUMULATIVE AMOUNT OF FAIR VALUE HEDGING ADJUSTMENT INCLUDED IN THE CARRYING AMOUNT OF THE HEDGED ASSETS/LIABILITIES | $ 22 | $ 24 |
Derivative Instruments - Effect
Derivative Instruments - Effect of Derivative Instruments Designated as Fair Value Hedges (Details) - Interest rate derivatives - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Derivative [Line Items] | ||
Hedged items | $ (9) | $ 39 |
Derivatives designated as hedging instruments | 9 | (39) |
Total | $ 0 | $ 0 |
Derivative Instruments - Effe_2
Derivative Instruments - Effect of Derivative Instruments Not Designated as Hedges on Consolidated Statements of Operations (Details) - Derivatives not designated as hedging instruments: - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||
Total gains (losses) | $ (205) | $ (98) |
Foreign currency derivatives | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Total gains (losses) | (130) | (72) |
Total return swaps—deferred compensation | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Total gains (losses) | (77) | (25) |
Equity derivatives | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Total gains (losses) | $ 2 | $ (1) |
Derivative Instruments - Schedu
Derivative Instruments - Schedule of Notional Amounts of Derivatives Outstanding (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Derivative [Line Items] | ||
Derivatives | $ 7,955 | $ 7,711 |
Foreign currency derivatives | ||
Derivative [Line Items] | ||
Derivatives | 5,672 | 5,419 |
Interest rate derivatives | ||
Derivative [Line Items] | ||
Derivatives | 1,500 | 1,500 |
Total return swaps—deferred compensation | ||
Derivative [Line Items] | ||
Derivatives | $ 783 | $ 792 |
Derivative Instruments - Additi
Derivative Instruments - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Jul. 29, 2023 | |
Derivative [Line Items] | ||
Net cash collateral provided for | $ 9 | $ 40 |
Cash flow hedges | ||
Derivative [Line Items] | ||
Derivative average remaining maturity | 24 months | |
Net investment hedges | ||
Derivative [Line Items] | ||
Derivative average remaining maturity | 6 months |
Commitments and Contingencies -
Commitments and Contingencies - Schedule of Purchase Commitments (Details) - Inventories - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Unrecorded Unconditional Purchase Obligation [Line Items] | ||
Less than 1 year | $ 4,731 | $ 5,270 |
1 to 3 years | 1,646 | 1,783 |
3 to 5 years | 127 | 200 |
Total | $ 6,504 | $ 7,253 |
Commitments and Contingencies_2
Commitments and Contingencies - Additional Information (Details) $ in Millions | 3 Months Ended | 8 Months Ended | 23 Months Ended | 87 Months Ended | ||||||||||
May 24, 2023 patent | Nov. 22, 2022 patent claim | Dec. 10, 2021 patent | Feb. 26, 2021 patent | Oct. 05, 2020 USD ($) patent | Jun. 12, 2019 patent | Feb. 13, 2018 patent | Aug. 08, 2016 patent | Oct. 28, 2023 USD ($) | Oct. 29, 2022 USD ($) | May 24, 2022 claim | Feb. 28, 2022 claim patent | Oct. 28, 2023 USD ($) patent | Jul. 29, 2023 USD ($) | |
Loss Contingencies [Line Items] | ||||||||||||||
Future compensation expense & contingent consideration (up to) | $ 437 | $ 437 | ||||||||||||
Commitments and contingencies | ||||||||||||||
Volume of channel partner financing | 8,200 | $ 7,600 | ||||||||||||
Balance of the channel partner financing subject to guarantees | 1,500 | $ 1,500 | 1,700 | |||||||||||
Brazilian tax authority | Tax Year 2003 - 2007 | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Income tax examination, tax | 162 | |||||||||||||
Income tax examination, interest | 943 | |||||||||||||
Income tax examination, penalties | $ 402 | |||||||||||||
Pending litigation | Centripetal | United States | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Damages awarded, value | $ 1,900 | |||||||||||||
Pending litigation | Centripetal | Patent infringement | United States | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Number of allegedly infringed patents (patent) | patent | 11 | |||||||||||||
Number of patents found infringed (patent) | patent | 4 | |||||||||||||
Damages awarded, pre-judgement interest | $ 14 | |||||||||||||
Royalty awarded against revenue, first three-year term, percentage | 10% | |||||||||||||
Royalty awarded against revenue, second three-year term, percentage | 5% | |||||||||||||
Number of patents found not infringed (patent) | patent | 1 | |||||||||||||
Pending litigation | Centripetal | Patent infringement | German | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Number of allegedly infringed patents (patent) | patent | 5 | |||||||||||||
Number of patents found not infringed (patent) | patent | 1 | 2 | ||||||||||||
Claims filed | claim | 2 | |||||||||||||
Pending litigation | Centripetal | Patent infringement, not subject to IPR proceedings | United States | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Number of allegedly infringed patents (patent) | patent | 5 | |||||||||||||
Pending litigation | Centripetal | Utility model infringement | German | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Claims filed | claim | 1 | |||||||||||||
Pending litigation | Ramot | Patent infringement | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Number of allegedly infringed patents (patent) | patent | 2 | 3 | ||||||||||||
Claims filed | claim | 2 | |||||||||||||
Pending litigation | Egenera | Patent infringement | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Number of allegedly infringed patents (patent) | patent | 3 | |||||||||||||
Number of patents found not infringed (patent) | patent | 2 | |||||||||||||
Minimum | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Warranty period for products | 90 days | |||||||||||||
Channel partners revolving short-term financing payment term | 60 days | |||||||||||||
Minimum | Pending litigation | Centripetal | Patent infringement | United States | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Annual royalty awarded against revenue, first three-year term | $ 168 | |||||||||||||
Annual royalty awarded against revenue, second three-year term | 84 | |||||||||||||
Maximum | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Warranty period for products | 5 years | |||||||||||||
Channel partners revolving short-term financing payment term | 90 days | |||||||||||||
Maximum | Pending litigation | Centripetal | Patent infringement | United States | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Annual royalty awarded against revenue, first three-year term | 300 | |||||||||||||
Annual royalty awarded against revenue, second three-year term | $ 150 | |||||||||||||
Investments in privately held companies | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Commitments and contingencies | $ 300 | $ 300 | 300 | |||||||||||
Inventories | ||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||
Liability for purchase commitments | $ 510 | $ 510 | $ 529 |
Commitments and Contingencies_3
Commitments and Contingencies - Schedule of Other Commitments (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Acquisitions | ||
Contingency [Line Items] | ||
Compensation expense related to acquisitions | $ 49 | $ 74 |
Commitments and Contingencies_4
Commitments and Contingencies - Schedule of Product Warranty Liability (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] | ||
Balance at beginning of period | $ 329 | $ 333 |
Provisions for warranties issued | 98 | 97 |
Adjustments for pre-existing warranties | 3 | 1 |
Settlements | (100) | (108) |
Balance at end of period | $ 330 | $ 323 |
Commitments and Contingencies_5
Commitments and Contingencies - Schedule of Financing Guarantees Outstanding (Details) - USD ($) $ in Millions | Oct. 28, 2023 | Jul. 29, 2023 |
Loss Contingencies [Line Items] | ||
Total | $ 113 | $ 125 |
Channel partner | ||
Loss Contingencies [Line Items] | ||
Maximum potential future payments | 142 | 159 |
Deferred revenue | $ (29) | $ (34) |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |||
Nov. 15, 2023 | Oct. 28, 2023 | Oct. 29, 2022 | Jul. 29, 2023 | |
Class of Stock [Line Items] | ||||
Remaining authorized repurchase amount | $ 9,700 | |||
Cash dividends declared (in dollars per share) | $ 0.39 | $ 0.38 | ||
Subsequent event | ||||
Class of Stock [Line Items] | ||||
Cash dividends declared (in dollars per share) | $ 0.39 | |||
Stock repurchase program | ||||
Class of Stock [Line Items] | ||||
Stock repurchases pending settlement | $ 48 |
Stockholders' Equity - Stock Re
Stockholders' Equity - Stock Repurchase Program (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | ||||
Oct. 28, 2023 | Jul. 29, 2023 | Apr. 29, 2023 | Jan. 28, 2023 | Oct. 29, 2022 | |
Stockholders' Equity Note [Abstract] | |||||
Shares (in shares) | 23 | 25 | 25 | 26 | 12 |
Weighted-Average Price per Share (in dollars per share) | $ 54.53 | $ 50.49 | $ 49.45 | $ 47.72 | $ 43.76 |
Amount | $ 1,252 | $ 1,254 | $ 1,259 | $ 1,256 | $ 502 |
Employee Benefit Plans - Additi
Employee Benefit Plans - Additional Information (Details) $ in Billions | 3 Months Ended | |
Oct. 28, 2023 USD ($) period stock_incentive_plan shares | Oct. 29, 2022 shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number of stock incentive plans (stock incentive plan) | stock_incentive_plan | 1 | |
Total compensation cost related to unvested share-based awards | $ | $ 4.5 | |
Expected period of recognition of compensation cost | 2 years 1 month 6 days | |
Employee Stock Purchase Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Consecutive offering period | 24 months | |
Number of purchase periods | period | 4 | |
Purchase period | 6 months | |
ESPP discount percentage from market price, beginning of purchase period | 15% | |
Shares issued under employee purchase plan (in shares) | 0 | 0 |
Shares reserved for issuance (in shares) | 88,000,000 | |
2005 Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Reduction in shares available for issuance (in shares) | 1.5 | |
Shares authorized for future grant (in shares) | 114,000,000 |
Employee Benefit Plans - Summar
Employee Benefit Plans - Summary of Share-Based Compensation Expense (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total share-based compensation expense | $ 661 | $ 496 |
Income tax benefit for share-based compensation | 143 | 99 |
Share-based compensation expense in cost of sales | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total share-based compensation expense | 103 | 81 |
Research and development | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total share-based compensation expense | 274 | 204 |
Sales and marketing | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total share-based compensation expense | 186 | 153 |
General and administrative | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total share-based compensation expense | 90 | 58 |
Restructuring and other charges | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total share-based compensation expense | 8 | 0 |
Share-based compensation expense in operating expenses | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total share-based compensation expense | 558 | 415 |
Product | Share-based compensation expense in cost of sales | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total share-based compensation expense | 42 | 31 |
Services | Share-based compensation expense in cost of sales | ||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
Total share-based compensation expense | $ 61 | $ 50 |
Employee Benefit Plans - Summ_2
Employee Benefit Plans - Summary of Restricted Stock and Stock Unit Activity (Details) - Restricted Stock Units - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | 12 Months Ended |
Oct. 28, 2023 | Jul. 29, 2023 | |
Restricted Stock/ Stock Units | ||
Beginning balance (in shares) | 122 | 97 |
Granted and assumed (in shares) | 11 | 72 |
Vested (in shares) | (9) | (39) |
Canceled/forfeited/other (in shares) | (1) | (8) |
Ending balance (in shares) | 123 | 122 |
Weighted-Average Grant Date Fair Value per Share | ||
Beginning balance (in dollars per share) | $ 44.04 | $ 46.67 |
Granted and assumed (in dollars per share) | 51.70 | 42.08 |
Vested (in dollars per share) | 44.86 | 46.69 |
Canceled/forfeited/other (in dollars per share) | 41.31 | 45.17 |
Ending balance (in dollars per share) | $ 44.69 | $ 44.04 |
Aggregate Fair Value | ||
Vested | $ 460 | $ 1,746 |
Comprehensive Income (Loss) (De
Comprehensive Income (Loss) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||
Beginning balance | $ 44,353 | $ 39,773 |
Other comprehensive income (loss) before reclassifications | (488) | (579) |
(Gains) losses reclassified out of AOCI | 7 | (13) |
Tax benefit (expense) | 31 | 96 |
Ending balance | 45,210 | 40,272 |
Accumulated Other Comprehensive Income (Loss) | ||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||
Beginning balance | (1,575) | (1,622) |
Ending balance | (2,025) | (2,118) |
Net Unrealized Gains (Losses) on Available-for-Sale Investments | ||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||
Beginning balance | (440) | (379) |
Other comprehensive income (loss) before reclassifications | (170) | (329) |
(Gains) losses reclassified out of AOCI | 20 | 6 |
Tax benefit (expense) | 36 | 77 |
Ending balance | (554) | (625) |
Net Unrealized Gains (Losses) Cash Flow Hedging Instruments | ||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||
Beginning balance | 18 | 44 |
Other comprehensive income (loss) before reclassifications | 38 | 32 |
(Gains) losses reclassified out of AOCI | (12) | (19) |
Tax benefit (expense) | (6) | (3) |
Ending balance | 38 | 54 |
Cumulative Translation Adjustment and Actuarial Gains (Losses) | ||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | ||
Beginning balance | (1,153) | (1,287) |
Other comprehensive income (loss) before reclassifications | (356) | (282) |
(Gains) losses reclassified out of AOCI | (1) | 0 |
Tax benefit (expense) | 1 | 22 |
Ending balance | $ (1,509) | $ (1,547) |
Income Taxes - Income Before Pr
Income Taxes - Income Before Provision for Income Taxes (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Income Tax Disclosure [Abstract] | ||
Income before provision for income taxes | $ 4,442 | $ 3,475 |
Provision for income taxes | $ 804 | $ 805 |
Effective tax rate | 18.10% | 23.20% |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) $ in Billions | Oct. 28, 2023 USD ($) |
Income Tax Disclosure [Abstract] | |
Unrecognized tax benefits | $ 1.9 |
Unrecognized tax benefits that would impact effective tax rate | $ 1.5 |
Segment Information and Major_3
Segment Information and Major Customers - Additional Information (Details) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 USD ($) segment | Oct. 29, 2022 USD ($) | |
Segment Reporting Information [Line Items] | ||
Number of geographic segments | segment | 3 | |
Revenue | $ 14,668 | $ 13,632 |
United States | ||
Segment Reporting Information [Line Items] | ||
Revenue | $ 8,100 | $ 7,100 |
Segment Information and Major_4
Segment Information and Major Customers - Summary of Reportable Segments (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Segment Reporting Information [Line Items] | ||
Revenue | $ 14,668 | $ 13,632 |
Gross margin | 9,557 | 8,346 |
Operating segments | ||
Segment Reporting Information [Line Items] | ||
Gross margin | 9,841 | 8,582 |
Operating segments | Americas | ||
Segment Reporting Information [Line Items] | ||
Revenue | 9,022 | 7,914 |
Gross margin | 5,968 | 4,984 |
Operating segments | EMEA | ||
Segment Reporting Information [Line Items] | ||
Revenue | 3,664 | 3,675 |
Gross margin | 2,545 | 2,325 |
Operating segments | APJC | ||
Segment Reporting Information [Line Items] | ||
Revenue | 1,982 | 2,043 |
Gross margin | 1,328 | 1,274 |
Unallocated corporate items | ||
Segment Reporting Information [Line Items] | ||
Gross margin | $ (284) | $ (236) |
Segment Information and Major_5
Segment Information and Major Customers - Summary of Net Revenue for Groups of Similar Products and Services (Details) - USD ($) $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Segment Reporting, Revenue Reconciling Item [Line Items] | ||
Revenue | $ 14,668 | $ 13,632 |
Total Product | ||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||
Revenue | 11,139 | 10,245 |
Networking | ||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||
Revenue | 8,822 | 8,031 |
Security | ||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||
Revenue | 1,010 | 971 |
Collaboration | ||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||
Revenue | 1,117 | 1,086 |
Observability | ||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||
Revenue | 190 | 157 |
Services | ||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||
Revenue | $ 3,529 | $ 3,387 |
Net Income per Share - Calculat
Net Income per Share - Calculation of Basic and Diluted Net Income per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | |
Oct. 28, 2023 | Oct. 29, 2022 | |
Earnings Per Share [Abstract] | ||
Net income | $ 3,638 | $ 2,670 |
Weighted-average shares—basic (in shares) | 4,057 | 4,108 |
Effect of dilutive potential common shares (in shares) | 30 | 8 |
Weighted-average shares—diluted (in shares) | 4,087 | 4,116 |
Net income per share—basic (in dollars per share) | $ 0.90 | $ 0.65 |
Net income per share—diluted (in dollars per share) | $ 0.89 | $ 0.65 |
Antidilutive employee share-based awards, excluded (in shares) | 16 | 38 |